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C-type lectin-like domain (CTLD) proteins, are mainly known for the crucial roles they play in 
vertebrate immunity. They function primarily as pattern recognition receptors (PRRs) to identify 
components of pathogenic intruders, but also as antimicrobial molecules to eliminate pathogens. In 
invertebrates the exact function of CTLD proteins in immunity is less described despite of the abundance 
of their encoding genes in many metazoan genomes. One of the most studied model organism – 
Caenorhabditis elegans – particular stands out for its enormous set of highly diversified CTLD proteins, 
which has the potential to generate immune specificity. Surprisingly, their exact function and 
contribution to C. elegans immunity still remains elusive. 
During my PhD I systematically screened the CTLD gene (clec) repertoire of C. elegans to identify 
genes that are involved in the defense against the two bacterial pathogens Pseudomonas aeruginosa 
(PA) and Bacillus thuringiensis (BT). Unexpectedly, in the tested mutants clec-knock-out led equally to 
susceptibility and resistance to pathogen infection, indicating that clec genes mediate both immune 
activation and suppression. Resistance of clec mutants on BT could partially be explained by enhanced 
pathogen avoidance behavior. We could confirm for the clec gene C54G4.4 that it negatively regulates 
behavioral immune responses and thus demonstrated for the first time that beside a potential contribution 
to the physiological immune system, clec genes might also function in behavioral immunity. 
In parallel to identifying clec immune response genes by a candidate mutant screen, we analyzed the 
expression of clec genes upon infection and stress using a database for C. elegans expression data. We 
identified clec-4 as another interesting candidate, due to its highly up-regulated profile upon exposure 
to many pathogens and stresses. Surprisingly, the clec-4 mutant showed resistance towards infection 
with BT, which suggests a function in negative regulation of the immune response. We further examined 
the role of one co- and one contra-expressed clec-4 paralog, clec-41 and clec-10, respectively, which 
were required for defense against BT infection and both suppressed the resistance phenotype of the 
clec-4 mutant. These findings give hint to a complex regulation network of interacting clec genes. 
Moreover, we started to analyze the function of the recombinant CLEC-4 protein in pathogen binding 
assays.  
Taken together, our work is the first step towards a more detailed analysis of the exact clec/CLEC 




Proteine mit einer C-Typ Lektin-ähnlichen Domäne (CTLD) sind vor allem für ihren essentiellen 
Beitrag im Immunsystem der Vertebraten bekannt. Dort agieren sie hauptsächlich als 
Mustererkennungsrezeptoren (PRRs), indem sie pathogene Strukturmotive identifizieren, oder aber als 
antimikrobielle Moleküle, die Pathogene eliminieren. Im Immunsystem von Invertebraten ist die 
Aufgabe der CTLD-Proteine weitaus weniger erforscht, obwohl deren kodierende Gene in vielen 
metazoischen Genomen zahlreich vertreten sind. Besonders Caenorhabditis elegans – einer der meist 
untersuchten Modellorganismen – sticht durch seine enorme Menge an stark diversifizierten CTLD-
Proteinen hervor, die das Potenzial haben, Immunspezifität zu erzeugen. Dennoch weiß man kaum etwas 
über die genaue Funktion und ihren Beitrag zur Immunabwehr bei C. elegans. 
Während meiner Doktorarbeit habe ich das Repertoire der CTLD-Gene (clecs) von C. elegans 
systematisch untersucht, um Gene, die bei der Immunabwehr gegen zwei bakterielle Pathogene – 
Pseudomonas aeruginosa (PA) und Bacillus thuringiensis (BT) – beteiligt sind, zu identifizieren. Die 
getesteten Knockout-Mutanten zeigten gleichermaßen Resistenz sowie Anfälligkeit gegenüber der 
Pathogeninfektion. Dies weist darauf hin, dass clec-Gene das Immunsystem sowohl aktivieren als auch 
unterdrücken können. Die Resistenz der clec-Mutanten auf BT konnte teilweise durch das erhöhte 
Pathogenvermeidungsverhalten erklärt werden. Zudem bestätigten wir, dass das clec-Gen C54G4.4 das 
Vermeidungsverhalten negativ reguliert. Neben der potentiellen Beteiligung an der physiologischen 
Immunantwort konnten wir somit für clec-Gene erstmals einen Einfluss auf das Immunverhalten 
nachweisen. 
Um weitere interessante Kandidaten zu ermitteln, untersuchten wir gleichzeit mit Hilfe einer C. elegans-
Transkriptomdatenbank die Expression von clec-Genen nach Infektion und Stress. Die Wahl fiel auf 
clec-4, da dieses clec-Gen nach Infektion mit einer Vielzahl von Pathogenen und Stress ein 
hochreguliertes Profil aufwies. Die clec-4-Mutante zeigte eine unerwartete Resistenz gegenüber 
Infektion mit BT, was möglicherweise mit einer negativen Regulation der Immunantwort erklärt werden 
kann. Des Weiteren untersuchten wir zwei clec-4 Paraloge, clec-41 und clec-10. Trotz Co-Regulation 
bzw. Contra-Regulation mit clec-4 wurden beide für die Immunabwehr gegen BT benötigt und 
unterdrückten zudem den Resistenzphänotyp von clec-4. Diese Ergebnisse deuten auf ein komplexes 
Regulationsnetzwerk hin, in dem clec-Gene miteinander interagieren. Darüber hinaus haben wir mit 
Hilfe von mikrobiellen Bindungsexperimenten begonnen, die Funktion des rekombinanten CLEC-4-
Proteins zu analysieren. 
Zusammenfassend ist unsere Arbeit ein erster Schritt zu einer detaillierten Analyse der genauen 




In this PhD project I addressed the immune defenses of an invertebrate host, Caenorhabditis elegans, 
against two bacterial pathogens, Gram-positive Bacillus thuringiensis and Gram-negative Pseudomonas 
aeruginosa. I was particularly interested in the involvement of C-type lectin-like domain genes and 
proteins questioning their exact functions in immune regulation and pathogen recognition or clearance. 
The model system C. elegans with its immune system, the pathogenic antagonists as well as the group 
of C-type lectin-like domain genes/proteins will be in detail discussed on the following pages. 
Caenorhabditis elegans – the Flagship Model of Invertebrates 
Caenorhabditis elegans (Figure 1) is a small, free-living nematode, which occurs in nature primarily in 
rotting material1,2. It mainly exists as a self-fertilizing hermaphrodite, yet males appear infrequently in 
a low percentage of the hermaphrodite’s progeny (e.g. 0.1-0.2% in the commonly used strain N2) due 
to a non-disjunction of the X chromosome or in approximately 50% after mating with males. The 
nematode passes four larval stages (L1-L4), which are defined by a molting event at the end of each 
stage leading to reproducible adulthood. When exposed to stress C. elegans may undergo an alternative 
cycle where the L2 larvae enter an almost indefinite dauer stage until favorable conditions induce the 
transition to the L4 stage3. 
 
 
Figure 1. Microscopic picture of C. elegans hermaphrodite wild type adult. Photo was taken using Zeiss Axio 
Observer Z.1 (Carl Zeiss AG, Jena, Germany) with 40 x magnification. Single pictures were stitched and edited 
with image editing software GIMP 2.8.14 (http://www.gimp.org/). The scale bar represents 0.1 mm. 
 
When Sydney Brenner first introduced C. elegans as model organism4 he laid the foundation for a 
plethora of significant discoveries in life sciences, some even awarded with Nobel prizes in different 
disciplines5–7. The reasons for the worm’s crusade through biological and medical research are 
numerous. Such a small animal – as adult it reaches about 1 mm in length – is easy and cheap to maintain 
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as it can be held in large numbers on Petri dishes, fed with bacteria, and one life cycle from egg to adult 
only takes 2.5 days at room temperature. The transparency facilitates to observe cellular processes under 
the microscope in vivo (Figure 1) which led to a description of every cell’s fate already decades ago8, 
not to mention the constant cell number of 959 in hermaphrodites and 1031 in males. However, there is 
one major advantage researchers working with other multicellular model organisms can only dream of: 
C. elegans can be frozen unlimitedly at -80 °C and revived within minutes after thawing. Furthermore, 
besides the fully sequenced genome9 a variety of different genetic tools are available ranging from RNA 
interference10, comprehensive mutant libraries (e.g. Caenorhabditis Genetics Center, National 
BioResource Project), and GFP tagging11 (e.g. Figure 2B) to novel technologies like CRISPR-Cas9-
mediated gene editing12. Taking these facts together it is not surprising that C. elegans nowadays is one 
of the leading multicellular models in research laboratories worldwide with a constantly growing “worm 
community”. 
C. elegans as a Model for Studying Immunity  
As discussed above C. elegans provides remarkable advantages for research but what makes it so special 
for studying immunity? 
In general, the simplicity of model organisms enables scientists to focus on certain aspects postponing 
the complex processes to higher organisms. As invertebrate C. elegans lacks an adaptive immune 
response engaging professional immune cells (e.g. T and B lymphocytes), which facilitates research 
purely on the innate immune system. The fact that common immune regulators (e.g. NF-κB, MyD88) 
are absent or do not play a crucial role in immunity as in vertebrates (e.g. TOL-113), opens up the 
possibility to decipher alternative mechanisms of how a host fights pathogenic intruders. 
Simultaneously, key questions on the evolution of immune systems can be addressed as defensive 
strategies of vertebrates and invertebrates share impressive similarities14. 
However, despite of its “basic” immune response the nematode exhibits exceptional strategies to sustain 
in a microbe-rich environment. 
Behavioral Defenses 
The first, yet in classical immunology widely overlooked, strategy to prevent pathogenic infection is the 
behavioral avoidance of encountering or/and ingesting harmful microbes. 
C. elegans is capable of discriminating harmful microbes from food bacteria and responds accordingly 
by physical avoidance before mounting a physiological response. The latter is not only costly15 but might 
also lead to collateral host damage since reactive oxygen species (ROS) production can be a response 
towards a pathogen16. The exact microbial cues which are sensed by the worm can be volatile or water-
soluble compounds mostly deriving from bacterial metabolism by-products17. Examples for bacteria-
originated repellents are the surfactant serrawettin produced by Serratia marcescens18 or the secondary 
9 
metabolites phenazine-1-carbooxamide and pyochelin secreted by Pseudomonas aeruginosa19. But 
there is also indication for an indirect recognition by cellular damage being a supplementary trigger of 
aversive behavior as non-pathogenic bacteria do not initiate immune behavior while native non-
pathogenic bacteria expressing toxins do20. 
The key players in chemosensory regulation of pathogen avoidance are the eleven pairs of ciliated 
amphid neurons in the head17. Some of them have been shown to be implicated in two neural circuits: 
the AWB and AWC neurons mediate the innate olfactory preference for bacteria via expression of 
neurotransmitters and neuropeptides18, whereas the ADF neurons are rather responsible for the aversive 
learning response, a behavior of wild type worms studied on P. aeruginosa, where initial attraction to 
the bacterial lawn turns after a learning phase into avoidance21,22. The aversive learning is based on 
serotonin-signaling through the tryptophan hydroxylase TPH-1 as the limiting factor in serotonin 
synthesis23. The recognition of environmental cues on the molecular level might be modulated by a 
superfamily of putative chemoreceptors with more than 1000 predicted members, namely the G protein-
coupled receptors (GPCRs), since a reasonable number is expressed in the amphid neurons24. Other 
sensory neurons likewise contribute to the modulation of immune behavior, e.g. HECT domain-
containing E3 ubiquitin ligase encoding hecw-1 is expressed in the OLL mechanosensory neurons to 
repress npr-125, which in turn is required to promote oxygen-dependent avoidance26. 
Additionally, as mentioned above, C. elegans might react to pathogen exposure with feeding cessation 
which is mediated by the insulin-like receptor (ILR) pathway27. 
Physical Barriers 
If host and pathogen eventually encounter each other entering the host is hampered by physical barriers. 
The cuticle as most apparent obstacle provides a thick, impermeable surface, which should prevent 
attachment of pathogens that attack from the outside, such as Drechmeria coniospora28 or 
Microbacterium nematophilum29. A more common route for pathogens to establish intestinal infections 
in the host is the mouth. Therefore, a mechanic structure in the second bulb of the pharynx, called grinder 
(Figure 1), protects this opening by destroying sucked in bacteria as first line of digestion but also 
defense30.  
Physiological Response – Recognition, Processing and Elimination 
The final defense mechanism is the induction of physiological responses to fight off and clear pathogen 
attack. The inducible immune response comprises three main steps: (i) the recognition of microbe-
associated molecular patterns (MAMPs) or damage-associated molecular patterns (DAMPs) by pattern 
recognition receptors (PRRs), (ii) consequent signaling forwarding the received information to 
transcription factors, which mediate (iii) expression of effector molecules, that eventually eliminate the 
intruders31. These levels will be discussed in the following one by one. 
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PRRs in C. elegans have long been a subject of immunological studies since the worm lacks prominent 
immune receptors that fulfill the task of pattern recognition in higher organisms’ innate immunity. For 
example, the only Toll-like receptor (TLR) orthologue TOL-1 does not hold the crucial function of 
initiating antimicrobial peptide (AMP) expression upon pathogen perception as it does in Drosophila 
and many vertebrates13, and other PRRs like NOD-like receptors (NLRs) of vertebrates do not exist at 
all32. C-type lectin-like domain (CTLD) proteins, which will be discussed in depth throughout the thesis, 
as well as the aforementioned chemosensory GPCRs have been proposed as potential PRRs33,34. An 
example for the latter is FSHR-1, which is required for defense against several pathogens and oxidative 
stresses but also pathogen avoidance, and acts independently of known immune pathways in the 
intestine35,36. More detailed findings for a function of a GPCR in pathogen recognition could be 
demonstrated by Zugasti and colleagues, who identified the GPCR DCAR-1 with its endogenous ligand 
HPLA (4-hydroxyphenyllactic acid), a DAMP generated upon disruption of the epidermis by 
D. coniospora or wounding. DCAR-1 acts in the epidermis to modulate the expression of AMPs through 
the conserved p38 mitogen-activated protein kinase (MAPK) cascade (see below)37. Together with the 
RIG-I (retinoic acid inducible gene)-like helicase DRH-1 (dicer related helicase), which is a receptor 
for virus-derived RNA38 these two receptors are heretofore the only PRRs described in C. elegans.  
Despite the knowledge gap on how C. elegans recognizes pathogenic attack the several intermediate 
signaling pathways activating the expression of effector molecules have been described and repeatedly 
reviewed31,39. With regards to the model system used in this study I will focus on the most relevant 
pathways implicated in the intestinal host response to Bacillus thuringiensis and P. aeruginosa (see 
“Pathogens and their Interaction with C. elegans” and Figure 2A). 
 
immune signaling cascades and main modulators mentioned in the 
text. Scheme adapted from 40–44. (B) Transgenic strain TJ356 
carrying the reporter construct daf-16::GFP. In healthy worms 
DAF-16 is present in the cytoplasm (left) but upon infection or 
stress (here: heat stress) it translocates into the nuclei (right). Parts 
of the mid body of young adults are shown. Pictures were taken 
with Zeiss Axio Observer Z.1 (Carl Zeiss AG, Jena, Germany) by 
Marco Grasse. The scale bars indicate 30 µm. 
 
Figure 2. Interaction of immune signaling components and 
translocation of DAF-16. (A) The simplified scheme only shows the  
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The principal and most ancient immune cascade is the conserved p38 MAPK pathway with its key 
kinase regulators NSY-1, SEK-1, and PMK-1. First described in 2002 upon infection with 
P. aeruginosa41 it shortly was shown to be implicated in the defense against a variety of bacterial and 
fungal pathogens, e.g.45–47. Upstream of the p38 cascade acts Toll-interleukin 1 receptor TIR-1, which 
contains multiple leucine-rich repeats, a well-known feature of TLRs in plants and animals48. One of the 
downstream targets of PMK-1 was identified as the transcription factor ATF-7, which expresses 
infection-induced genes upon phosphorylation by PMK-146. The p38 MAPK requires the activation by 
a second MAPK pathway, the c-Jun N-terminal kinase (JNK) cascade previously shown to be involved 
in the stress response to heavy metal. MEK-1 and VHP-1 cross-regulate the activity of PMK-1 in 
pathogen defense40,49. In the immune response against pore-forming toxins (PFTs), as produced by 
B. thuringiensis, JNK-like MAPK KGB-1 even seems to be the central regulator for transcriptional 
induction of defense50 (Figure 2A). 
The ILR pathway including the receptor tyrosine kinase DAF-2 and the FoxO transcription factor 
DAF-16 has been discovered due to its role in longevity and dauer regulation51. Interestingly, daf-2 
mutants do not only live twice as long as the wild type52, but also exhibit resistance against multiple 
stresses (e.g. heavy metal, heat, or osmotic stress53–55) and pathogen exposure42,56. The activation of 
DAF-2 leads to the inactivation of DAF-16 in the cytoplasm whereas daf-2 deficiency results in an 
active nuclear DAF-16 inducing gene expression57. In how far DAF-16 contributes to resistance against 
pathogens or rather generally to stress is not yet clear. Pleading for the latter is the observation that the 
expression of PMK-1-dependent genes upon infection is repressed by DAF-16 but induced during 
stress58,59. Nonetheless, in a study from our group it was shown that DAF-16 directly translocates to the 
nucleus following B. thuringiensis exposure60 (Figure 2B). 
A further signaling cascade that interacts with the pivotal p38 MAPK pathway belongs as well to the 
compartment of stress response management, the unfolded protein response (UPR). Upon pathogen 
attack PMK-1 mediates in addition to expression of immune effector genes the activation of the UPR in 
order to handle cellular accumulation of un- and misfolded proteins. The UPR is thought to be the 
protective force against self-damage caused by AMPs of the immune defense61. The p38 MAPK-
dependent activation of the conserved IRE-1-XBP-1 branch of the UPR was shown to act in the defense 
against P. aeruginosa61 and B. thuringiensis’ PFTs44. Sun et al., moreover, presented a GPCR in the 
amphid neurons, OCTR-1 (octopamine receptor), to suppress the non-canonical UPR in non-neuronal 
tissue independent of behavioral pathogen avoidance43, suggesting an intervention of the nervous system 
in the immune response (Figure 2A). The mitochondrial UPR (UPRmt) additionally seems to promote 
resistance by protecting from mitochondrial damage caused by bacteria that target mitochondrial 
processes, like P. aeruginosa62. 
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After a successful signal transmission from PRRs via the signaling cascades to transcription factors, the 
expression of effector molecules is triggered. I will here focus on AMP expression and give some 
examples. C. elegans AMPs have been identified mostly by their up-regulation after pathogenic 
infection coupled with homology searches for known metazoan antimicrobial peptides and proteins. 
Based on that, several families are considered to hold antimicrobial activity, but the exact function has 
only been demonstrated for few proteins63,64. For example, the defensin-like peptide ABF-2 – identified 
through homology with Ascaris suum antibacterial factors (ASABFs)65, and consequently named 
Ce-ABF-2 or only ABF-2 – affects a broad range of pathogens but more strongly Gram-positive 
bacteria66. Caenopores or saposin-like proteins (SPPs), share similarities with amoebapores of the 
protozoan parasite Entamoeba histolytica. Several SPPs have been reported to display antimicrobial 
activity against a variety of bacteria, including P. aeruginosa and B. thuringiensis used in the present 
study, their expression – primarily in the intestine – is partially regulated via the ILR pathway67–70. 
Furthermore, genes encoding neuropeptide like peptides (NLPs) and the closely related caenacins 
(CNCs) are transcriptionally induced by infection with D. coniospora, the nlps additionally by 
S. marcescens infection in both intestinal and epidermal epithelium71,72. Yet, only NLP-31 has been 
reported to show antifungal activity at the protein level in vitro72.  
Despite the mentioned examples of research on AMP characterization C. elegans AMPs remain a poorly 
studied group of proteins due to the lack of functional studies on both the gene and protein level. 
Pathogens and their Interaction with C. elegans 
Another benefit of the model organism C. elegans is the large variety of infection agents, which can be 
applied in immunity studies. Since C. elegans lives in decaying organic matter, in other words microbe-
rich environments1,2, and as bacteriovore feeds on the very same, experimentally introducing intestinal 
pathogens is rather uncomplicated. Also many human pathogens are able to establish infections in the 
worm, which allows the investigation of clinically relevant host-pathogen interaction in vivo. A 
considerable diversity of microbes has been used to infect C. elegans; Gram-positive, Gram-negative, 
fungal, and microsporidial parasites with intestinal, epidermal, anal, and vulval routes of infection, 
applying a plethora of killing mechanisms31,73. In our study we employed the likely natural 
B. thuringiensis and human opportunistic pathogen P. aeruginosa, which will be introduced in more 
detail in the following.  
Bacillus thuringiensis – the Natural Pathogen 
Gram-positive B. thuringiensis (BT) is known especially for its application as biological pesticide, as 
alternative to chemical pesticides, and tool in genetic engineering to generate transgenic resistant crop 
in agriculture74,75. This utilization it owes to its ability to infect and kill a wide range of insect taxa such 
as lepidopterans, dipterans, hymenopterans, and coleopterans, serving the purpose as pest control76,77. 
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BT kills through PFTs called Cry toxins due to their crystalline structure (Figure 3A) produced during 
sporulation. Secreted by bacteria PFTs bind to host receptors, multimerize and pierce a hole into the 
plasma membrane eventually causing cell lysis and ion leakage. The solubilization of inactive pro-toxins 
by the gut’s milieu, the activation through proteolytic cleavage as well as the specificity of the receptor 
are inevitable parts of the infection process provided by the host after ingestion78,79(Figure 3B).  
 
 
Figure 3. Pathogenic B. thuringiensis with spores and crystals, and PFTs’ mode of infection. (A) Transmission 
electron microscopic picture of single sporulated BT cell taken from 80. (B) Scheme of infection by PFTs adapted 
from 79,81. 
 
The host spectrum of each BT strain is determined by its repertoire of Cry toxin encoding genes and is 
based almost exclusively on the presence of the specific toxin receptor81,82. For instance, Cry4Ba is 
specifically active against dipterans such as Anopheles and Aedes, Cry1Aa against Lepidopterans such 
as Diatraea and Chilo83–88, whereas synergistic combinations might expand the host spectrum89,90. 
The BT strains used in the following study are strain BT18247 which produces Cry6Ba191 and strain 
BT407 Cry- as non-pathogenic counterpart. 
B. thuringiensis vs. C. elegans 
More than a decade ago BT was introduced as a pathogen of model organism C. elegans in order to 
study its toxicity on parasitic nematodes, improve the understanding of the toxins’ mode of action92,93, 
and – most importantly for the C. elegans community – to learn more about the nematode’s immune 
response towards this potentially natural pathogen30,34. Commonly, the effect of BT toxins towards the 
worm is tested by applying toxin expressing E. coli instead of the complete bacterium or spore. Like 
this is has been demonstrated that C. elegans is susceptible to several Cry toxin variants94. But only 
Cry5B was used to discover Cry toxin-resistant mutants, which were resistant to Cry5B92 and cross-
resistant to Cry14A95. The underlying mutations were identified in the bre (Bacillus-toxin resistant) 
genes, which encode glycosyltransferases being involved in the synthesis of glycolipid receptors96. 
Thus, the ability of Cry5B and Cry14A expressing BT strains to infect C. elegans is modulated by these 
specific gut receptors. Alternatively, the glycolipid receptor can be actively blocked by C. elegans 
immune defenses promoting resistance due to competitive inhibition: Galectin LEC-8 is expressed in 
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the intestine upon Cry5B exposure and is able to bind to the very same receptors BT requires for 
infection, consequently preventing a successful docking of the virulence factor to the host tissue97. 
Resistance to exposure with Cry5B further requires components of the two aforementioned MAPK 
pathways, p38 and JNK-like cascade98, where the former activates UPR signaling44, which in turn 
interacts with the hypoxia pathway99. The ILR pathway, moreover, is mainly involved in the response 
to Cry6B produced by BT18247 in both physiological and behavioral immunity27,60. 
Pseudomonas aeruginosa – the Human Pathogen 
Pseudomonads are ubiquitously occurring Gram-negative bacteria, occupying a variety of different 
niches, with P. aeruginosa (PA) being the most extensively studied genus member100,101. First described 
in 1894102, PA quickly became the center of attention since it is a major threat of injured, burned and 
immuno-compromised patients in hospitals and might cause chronic pulmonary infections in cystic 
fibrosis patients103,104. Thus, it is not surprising that the most prominent PA strains research is done on, 
PA01 and PA14, originally arose from clinical isolates. Both strains were fully sequenced105,106, but the 
more virulent PA14 is nowadays predominantly subject of infection studies in a broad range of host 
organisms, such as plants, insects, other non-mammalian hosts107–111, and also antibiotic resistance 
research112. 
The ability to infect organisms of such evolutionary divergence might be associated with the multiplicity 
of virulence factors PA employs113. Key PA virulence factors are pyoverdin siderophores (also the 
reason for its characteristic green color) which sequester iron from the host, an embattled resource for 
redox enzymes among both pro- and eukaryotes114. The most toxic secreted virulence factor, exotoxin 
A, however, is known to inhibit the protein synthesis of eukaryotic host cells, eventually leading to cell 
death113,115. The whole PA toxin variety has been reviewed in e.g.116,117. 
P. aeruginosa vs. C. elegans 
PA is the most commonly applied bacterial pathogen in C. elegans immunity studies118. One major 
convenience of using the nematode as a model is that different PA toxins can be examined according to 
the set-up of infection. If worms are fed on high-osmolarity solid media, referred to as “fast killing”, 
diffusible toxins, such as phenazine pyocyanin, kill C. elegans within few hours. “Slow killing” happens, 
on the other hand, on low-nutrient media, where PA proliferates in the gut and causes typical symptoms 
of infection (e.g. paralysis, distended intestinal lumen) eventually leading to death after several 
days119,120. A modification of the latter method in liquid media identified pyoverdin as major infectious 
agent independent of the other previous mentioned factors121. 
Similar to the immune response to BT’s Cry toxins, PA infections activate the ancient p38 MAPK 
cascade in cross-talk with the JNK-like pathway41, and additional involvement of the transcription factor 
ZIP-2 and the already mentioned GPCR FSHR-1, particularly against exotoxin A122. Both slow and fast 
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killing can induce the UPRmt as a consequence of mitochondrial dysfunction62, whereas the UPR is 
activated in a microRNA-123 but also p38 MAPK-dependent manner61. Interestingly, PA is also able to 
actively manipulate the host’s immune response by suppressing the expression of immune effectors via 
the ILR pathway56. PA further elicits an aversive learning response as mentioned in section “Behavioral 
Defenses”. 
The Crucial Role of C-type Lectins in Vertebrate Innate Immunity 
C-type lectins are calcium-dependent (C-type) carbohydrate-binding lectins which share a characteristic 
carbohydrate-recognition domain (CRD)124. The CRD motif, however, does not necessarily confer 
sugar- nor calcium-binding activity which is why a more general term, the C-type lectin-like domain 
(CTLD) protein, was introduced125. CTLD proteins are mainly found throughout metazoan taxa but also 
– although more rarely – present in plants, bacteria, and viruses126. In innate immunity they are of crucial 
importance being involved in both, initial pathogen recognition and final pathogen elimination (cf. 
“Physiological Response – Recognition, Processing and Elimination”). 
C-type Lectin Receptors and their Immune Signaling 
C-type lectin receptors (CLRs) recognize MAMPs coming from diverse pathogens as well as DAMPs 
released by injured cells. Recognition of fungal infections is the best studied function of vertebrate 
CLRs. Dectin-1 and Dectin-2, for example confer protection against Candida albicans (among others), 
the causing agent of candidiasis in mucosal membranes127, by binding to different cell wall components, 
β-glucan or α-mannose respectively128,129. The binding affinity of Mincle and the mannose receptor 
(MR) has been shown to be directed against fungi, too, but also against few bacterial species, and 
regarding MR even viruses and protozoan parasites130,131. CLRs further have been associated with viral 
recognition, either by promoting (e.g. CLEC5A and dengue virus132) or counteracting (e.g. DNGR-1 
and vaccinia virus133) viral infections. The detection of DAMPs, such as F-actin and uric acid crystals, 
has been attributed to DNGR-1134,135 and Clec12a136, respectively (Figure 4A). Nevertheless, in contrast 
to their contribution to fighting fungal pathogenesis, classical CLRs acting in defense against bacterial 
infections are less described.  
For some transmembrane C-type lectins the cytoplasmic domain determines the direction of signaling: 
the immunoreceptor tyrosine-based activation motif (ITAM) or ITAM-like motif promote subsequent 
signaling (e.g. of Dectin-1, DNGR-1) while the immunoreceptor tyrosine-based inhibitory motif (ITIM) 
prevents inappropriate immune responses (e.g. of MICL). ITAM-containing CLRs are coupled to Syk 
(spleen tyrosine kinase)-signaling, resulting in activation of different immune responses that might 
involve MAPK pathways such as the p38, ERK, and JNK cascades, or NF-κB. These immune 
activations can be negatively regulated by ITIM-containing CLRs either directly at the ITAM site of 
other receptors or at the course of the activating signaling137. Interestingly, CLRs might synergistically 
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collaborate with each other (e.g. Dectin-1 and -2) but also with other types of PRRs (e.g. Dectin-1 and 
TLR2)131 (Figure 4A). 
 
 
Figure 4. Examples of C-type lectins in vertebrate immunity. (A) Simplified scheme of CLRs, which were 
mentioned in the text. Shown are the pathogens or endogenous constituents which they are able to recognize, 
their C-type lectin name as well as an alternative name, the domain architecture, and some major signaling 
components that lead to activation of the immune response. Adapted from 137–139. (B) Domain architecture and 
multimerization of MBL. Adapted from 140,141. (C) Model for pore-forming process of human RegIIIα. After 
activation of soluble pro-RegIIIα by trypsin, mature RegIIIα binds to peptidoglycan of Gram-positive bacteria and 
final oligomerization of monomers leads to formation of pore. Taken from 142. 
 
The Mannose-binding Lectin as Inducer of the Complement System 
Other important C-type lectins within vertebrate immunity are the secreted collectins (collagen-
containing C-type lectins). Here, I focus on the mannose-binding lectin (MBL) since it is the major 
regulator of the lectin pathway, which is next to the classical and the alternative pathway the 
evolutionary most ancient pathway to activate the complement system143,144. MBL circulates in the blood 
serum as a multimer of homotrimers which facilitates binding of more complex ligands (Figure 4B). 
The range of infectious agents being recognized by MBL comprises all principal pathogen groups with 
specific binding of mannose, fucose, and GlcNAc (N-acetyl-glucosamine) (summarized in 145,146). 
Furthermore, MBL is not only able to distinguish between self, non-self but also altered-self in the shape 
of necrotic, apoptotic or cancer cells147,148. Upon recognition of these MAMPs or DAMPs, MBL forms 
a complex with MBL-associated serine proteases (MASP1 and MASP2) at the collagenous region and 
is then able to induce/trigger complement activation. Thus, in interacting with the classical pathway 
MBL triggers inflammation, lysis and opsonization149. The crucial role of MBL has been repeatedly 
demonstrated as MBL-deficient patients suffer from increased infection and susceptibility to sepsis 
potentially leading to death150. 
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C-type Lectins as Effector Proteins 
Last but not least, vertebrate C-type lectins have also been shown to be directly involved in downstream 
processes of immunity, such as elimination of pathogens. The best examples for such C-type lectin 
effectors are members of the RegIII family. RegIIIγ in mice (RegIIIα in humans), for instance, is 
strongly expressed in the intestinal epithelium in a MyD88-dependent manner triggered by bacterial gut 
colonization and infection151,152. It interacts preferably with Gram-positive bacteria, as peptidoglycan is 
a ligand, but on the contrary is inhibited by lipopolysaccharide (LPS) in the cell wall of Gram-negative 
bacteria. Secreted into the gut lumen RegIIIγ attacks bacteria through oligomerization and pore 
formation and thereby limits the colonization of the epithelial surface142,151 (Figure 4C). The close 
relative RegIII acts similar to RegIIIγ, but targets to a greater extent Gram-negative bacteria due to 
binding of Lipid A of LPS153,154. Thus, these C-type lectins function as antimicrobial proteins and are 
thought to represent an evolutionary primitive innate immune response distinct from lectin-mediated 
complement activation, but critical for maintenance of the microbiome homeostasis in the gut142,151,152.  
C-type Lectins in C. elegans and other Invertebrates 
As above exemplarily summarized for vertebrates (specifically mice and humans), the multifaceted 
contribution of C-type lectins in immunity emphasizes the significance of this protein family in both the 
humoral and cellular arm of the innate immune defense and as supplement to adaptive defenses. But 
CTLD proteins also exist in various invertebrate taxa (e.g. 155–157), yet, their role in immunity is not as 
well explored. Only single C-type lectins have been implicated in promoting immune processes 
encompassing phagocytosis, encapsulation, or melanization (e.g. 158,159) and also directly in pathogen 
clearance (e.g. 160–162). Nevertheless, the indispensability of CTLD proteins in immune defenses like in 
vertebrates has not been demonstrated yet. That might not be surprising given the variety of defense 
strategies found in invertebrate taxa already in different species163. 
C. elegans has an intriguingly high number of genes encoding CTLD proteins, which are predicted to 
be very diverse164. The majority of the CTLD protein encoding genes (clecs) are organized in genomic 
clusters, which hints to a rapidly evolving gene family under strong selective pressure by co-evolving 
pathogens165. Together with their up-regulation upon various pathogenic threats and stresses CTLD 
proteins have always been considered to be involved in C. elegans immunity. But still we lack 
fundamental knowledge about the exact role they might play in defending the host organism. 
A more detailed and thorough discussion about CTLD proteins in invertebrate and particularly in 
C. elegans immunity is provided in the first chapter. 
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PhD Thesis Content 
The current PhD thesis addresses the role of clec genes and their encoded proteins as potential regulators 
of immunity in the model nematode C. elegans. The aim of the study was (i) to question the inevitable 
label given to clec genes as “immune genes” serving crucial functions in C. elegans immune defense, 
(ii) to systematically screen the clec gene repertoire in order to extract potential candidate immune genes, 
(iii) and ultimately to characterize the selected genes for their specific function in immunity. 
Chapter I represents a review on “High Innate Immune Specificity through Diversified C-type Lectin-
like Domain Proteins in Invertebrates”. It gives a detailed introduction into the current knowledge of 
clec gene and protein functions in invertebrate immunity. It deals with the issue of immune specificity 
in invertebrate organisms and suggests CTLD proteins as promising candidates for generating immune 
specificity. First compiling the latest findings in representative taxa (insects and crustaceans) the review 
then focuses on nematodes, which show extreme CTLD gene diversification. Uncovering the largely 
unknown functions of invertebrate CTLD proteins requires novel and comprehensive research 
approaches, which are discussed in the concluding remarks of the review. 
Chapter II is a manuscript that is now ready for submission. We here demonstrate that C. elegans clec 
genes might function in behavioral defense responses. A survival screen of clec gene knock-out mutants 
exposed to bacterial pathogens revealed resistant as well as susceptible phenotypes. The resistance 
phenotype correlated with the number of escaped worms. In a thorough analysis of the clec gene 
C54G4.4 we confirmed that CTLD proteins are involved in C. elegans immune behaviors. 
Another in depth analysis of one clec gene is described in Chapter III, which is a preliminary 
manuscript. Infection with several C. elegans pathogens leads to the strong up-regulation of clec-4. The 
knock-out unexpectedly showed a resistance survival phenotype on B. thuringiensis, which is 
suppressed by additional RNAi knock-down of the two clec-4 paralogs clec-41 and clec-10. This 
indicates that different clec genes mediate immune responses by interacting with each other. 
Furthermore, analysis of the recombinant protein provides indication that CLEC-4 binds certain 
bacterial pathogens. These results represent an exciting basis for untangling genetic networks within the 
clec superfamily and discovering potential antagonists of pathogenic intruders. 
The chapter Additional Results comprises obtained data on additional clec genes, which were 
insufficient to include in a manuscript. It contains the initial efforts to find interesting clec gene 
candidates by systematic RNAi screens of the majority of the clec genes repertoire and also more 
detailed analyses of selected clec genes. Furthermore, the in vivo expression pattern of some clec genes 
is shown and all generated transgenic reporter strains are compiled in a list that also gives information 
about the used transgene concentrations and primers. 
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 Supplementary Tables 
Table S1. Diversity of CTLD proteins in the C. elegans genome. 
Class Protein domainsa Totalb Secreted/membr.-boundc   Genomic clustersd  Pathogen-inductione 
  # # S # M # S + M  # Cluster names  # Pathogens 
                        
I 1 CTLD 144 115 8 13  65 I.1, I.2, I.3, II.2, II.3, 
II.4, III.1, IV.1, IV.2, 
IV.3, IV.4, IV.5, V.1, 
V.3, V.6, V.7, V.8 
 99 BM, BT, LR, SM, PL, EC, HA, EF, DC, 
ML, VC, SA, MN, YP, PA, XN 
 
II 2-3 CTLD 44 23 17 1  26 II.2, II.3, IV.4, IV.5, 
V.4, V.5 
 40 SM, EF, PL, HA, EC, ML, SA, DC, BT, 
PA 
 
III 1-3 CTLD + 1-3 CUB 31 22 1 7  9 II.1, V.2, V.6  25 MN, PL, PA, DC, EF, SM, HA, BT, 
XN, SA 
 
IV 1-2 CTLD + 1-2 CW 35 24 4 0  14 I.2, I.4, II.3, IV.4, V.8, 
V.9 
 20 HA, EF, SM, PL, DC, PA 
 
V 1 CTLD + 1-2 VWA 14 14 0 0  10 II.5, II.6  12 DC, EF, SM, PL, PA, HA, SA, MN, YP, 
BT, EC 
 
            
  
Class Protein domainsa Totalb Secreted/membr.-boundc   Genomic clustersd  Pathogen-inductione 
  # # S # M # S + M  # Cluster names  # Pathogens 
                        
VI Complex structure 15 4 2 8  1 I.3  11 EF, PL, SM, DC, HA, YP, BM 
 
            
Sum   283 202 32 29   125     207   
a Number of protein domains present. Domain abbreviations: CTLD, C-type lectin-like domain; CUB, Complement C1r/C1s Uegf Bmp1 domain; CW, conserved cysteine and tryptophan residues, Caenorhabditis-specific 
domain; VWA, Von Willebrand factor type A domain; Complex structure, complex domain structure, where CTLDs might not determine the actual function of the protein. 
b Total number (#) of CTLD proteins per class. 
c Number (#) of CTLD proteins with either signal sequence (S, secreted), transmembrane-spanning region (M, membr.-bound) or both according to SignalP 4.0 [48]. 
d Number (#) of clec genes within genomic clusters and their respective names. A genomic clusters is defined as at least three genes within a continuous 20 kb fragment. Roman and Arabic numbers of the cluster names 
refer to the chromosome and cluster position within each chromosome, respectively. 
e Number of microorganism-induced clec genes per CTLD class taken from previous gene expression studies [50,52,53,64–66,68–72,79–82]. Abbreviations for microorganisms as explained in figure 1 
  
 Table S2. Diversity of CTLD genes in Caenorhabditis genomes. 















# # S # M # S + M   # # S # M # S + M   # # S # M # S + M   # # S # M # S + M 
1 CTLD 107 79 5 7  71 35 3 7  85 54 6 6  166 98 7 15 
2-3 CTLD 48 30 8 5  9 4 1 1  21 15 2 0  26 16 3 2 
1-3 CTLD 
+ 1-3 CUB 
39 25 1 5  9 6 0 1  28 22 0 4  44 32 0 6 
1-2 CTLD 
+ 1-2 CW 
52 26 2 3  14 8 1 1  19 10 1 1  56 26 1 2 
1 CTLD 
+ 1-2 VWA 
33 28 1 0  4 1 0 1  18 13 0 1  15 12 0 1 
Complex  
Structure 
13 6 1 3  6 4 0 0  11 5 2 2  11 6 3 2 
                    
Sum 292 194 18 23   113 58 5 11   182 119 11 14   318 190 14 28 
a Number of protein domains present. Domain abbreviations as explained in table S1. 
b Total number (#) of CTLD proteins per class. 
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C-type lectin-like domain (CTLD) proteins occupy crucial functions in the immune system of 
vertebrates, but their role in invertebrate immunity is much less understood. The nematode 
Caenorhabditis elegans possesses a highly diverse CTLD protein encoding (clec) gene repertoire. A 
role of C. elegans clec genes in the immune response is always assumed, yet, experimental evidence for 
clec immune function is rare. To systematically test the contribution of clec genes to the C. elegans 
defense against pathogens, we screened 39 clec mutants for survival on the Gram-positive pathogen 
Bacillus thuringiensis (BT) and the Gram-negative pathogen Pseudomonas aeruginosa (PA14). We 
found that 41% of the tested clec mutants showed altered survival after infection on BT and 27% on 
PA14, exhibiting both increased susceptibility and resistance. As resistance to pathogen infection was 
positively correlated with escape behavior, we then investigated the role of C. elegans clec genes in 
pathogen avoidance behavior. We show that the highly resistant C54G4.4(ok2110) mutant exhibits a 
particularly strong avoidance phenotype combined with prolonged feeding cessation when exposed to 
BT. Together, our data suggest that C. elegans clec genes mediate both resistance and susceptibility to 




Metazoan C-type lectins are known to be involved in many cellular processes such as cell-cell adhesion 
or endocytosis1, but fulfill their most distinctive tasks in the context of immunity2. C-type lectins are 
characterized by their ability to recognize and bind carbohydrates (“lectins”) in a calcium-dependent 
(“C-type”) fashion. The sugar-protein interaction is mediated by a common sequence motif, the 
carbohydrate recognition domain (CRD)3. Although C-type lectins share primary and secondary 
structural homology in their CRDs, not all are capable of binding sugar nor calcium, hence, the more 
general term C-type lectin-like domain (CTLD) was introduced4,5.  
The function of CTLD proteins is best characterized in the vertebrate immune system, where CTLD 
proteins recognize pathogens as pattern recognition receptors (PRR) and modulate consequent immune 
responses (reviewed in 6). In invertebrates, the exact contribution of CTLD proteins to immunity is much 
less understood despite the genomic abundance of CTLD encoding genes in several taxa, e.g. insects7-10, 
echinodermata11,12, or nematodes13. There are, however, few examples of invertebrate CTLD proteins, 
for which a function in promoting phagocytosis, encapsulation, and melanization, or in initiating the 
prophenoloxidase-activating system could experimentally be demonstrated (e.g. 7,14–16). The nematode 
Caenorhabditis elegans has an exceptionally diversified repertoire of CTLD encoding (clec) genes 
composed of 283 members. In every gene expression study done in C. elegans after pathogen exposure 
several clec genes were found to be up-regulated, and that in a pathogen-specific manner (reviewed in 
13). It is thus generally assumed that C. elegans clec genes are involved in the immune response during 
pathogen infection. The experimental evidence for such a contribution to C. elegans immunity is, 
however, still restricted to a very limited number of clec genes: Few studies describe a susceptibility 
phenotype for clec mutants following an infection (e.g. 17,18) or demonstrate an intestinal expression of 
clec genes upon infection (e.g. 19). Only two studies examined CLEC function on the protein level20,21. 
In our study, we aimed at systematically testing the contribution of clec genes to the C. elegans defense 
against pathogens and screened 39 clec mutants for survival on the Gram-positive Bacillus thuringiensis 
(BT) and the Gram-negative Pseudomonas aeruginosa (PA14). 41% of the tested clec mutants showed 
altered susceptibility to infection on BT, 27% on PA14, surprisingly exhibiting both higher susceptibility 
and higher resistance. We noticed a positive correlation between resistance and pathogen avoidance and 
could confirm a role for the CTLD encoding gene C54G4.4 in avoidance behavior and feeding cessation. 




Materials and Methods 
Strains and Culture Conditions 
Worms were grown and maintained on nematode growth medium (NGM) agar plates seeded with 
Escherichia coli OP50 as previously described22. Wild type strain N2 (Bristol) and all clec mutant strains 
were obtained from the Caenorhabditis Genetics Center (CGC, Minnesota, USA) or the National 
BioResource Project (NBRP, Tokyo, Japan)23. The complete list of worm strains including their names, 
genotype, WormBase ID (Version WB250), and the source they were received from can be found in 
“Supplementary Tables and Figures” Table S1. 
The BT strains MY-BT18247 (in the following BT18247) and BT407 were originally obtained from the 
Agriculture Research Service Patent Culture Collection of Microorganisms and Cell Cultures (United 
States Department of Agriculture, Peoria, Illinois, USA). BT spore-toxin mixtures were generated 
according previous protocols24–26. The spore-toxin mixtures were frozen at -20 °C in 250 µl aliquots 
with a spore concentration ranging from 3*109 to 8*109 particles/ml for BT18247 and 
1.1*1010 particles/ml for BT407 and immediately used for C. elegans infection. The Pseudomonas 
aeruginosa strain PA14 (provided by Dennis Kim) was first grown on LB plates and then cultured 
overnight at 37 °C in LB broth prior to inoculation of assay plates. 
Survival, Avoidance, and Ingestion Assays 
Peptone free medium (PFM) agar plates (6 cm diameter) were inoculated with 75 µl of a mixture of BT 
spore-toxin mixture and E. coli OP50 in PBS (adjusted to OD 5) at different concentrations (e.g. 1:50 
and 1:100 in the initial screen). Plates were kept at 20 °C overnight. PA14 requires enriched NGM 
(0.35% instead of 0.25% peptone) for efficient “slow killing” of worms27. NGM plates seeded with a 
mixture of PA14 (OD 1) and E. coli OP50 (OD 5) at a concentration of 1:3 were incubated for 24 h at 
37 °C, followed by another incubation for 24 h at 25 °C28. The non-pathogenic BT407 and E. coli OP50 
were used as controls. Thirty synchronized worms at the fourth larval (L4) stage were picked onto each 
plate and survival was scored after 24 h for BT and 72 h for PA14 infection experiments. Worms were 
considered to be dead if they did not respond to light touch. 
For assays of pathogen avoidance behavior plates were prepared as above with the exception that only 
30 µl of the bacterial mixture were inoculated in the middle of the plate (9 cm diameter). Low BT 
concentrations were chosen in order to challenge, but not to kill the worms. Ten synchronized L4 
hermaphrodites were picked onto each bacterial treatment at time point 0 hpi (hours post infection) and 
the worms residing on that spot were scored every second hour. The avoidance index was calculated as 
follows: (initial total number of worms - worms on bacterial spot)/initial total number of worms. Dead 
individuals were excluded from the total number of worms per plate.  
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For measuring the bacterial uptake, synchronized L4 hermaphrodites were exposed to mild 
concentration as described above and the pumping of the grinder was measured in individual worms 
within 20 s after 1, 6, and 24 hpi. 
Statistical Analyses 
Statistical analyses were done with RStudio (Version 0.98.977), graphs created with its package ggplot2 
(Version 0.9.3.1) and edited with Inkscape (Version 0.48). 
Results and Discussion 
C. elegans clec mutants are both more resistant and more susceptible to 
infection with pathogenic BT and PA14. 
We aimed at systematically testing the contribution of clec genes to the C. elegans defense against 
infection with the Gram-positive pathogen BT and the Gram-negative pathogen PA14. We screened 
39 clec knock-out mutants that were available from the CGC and NBRP (“Supplementary Tables and 
Figures” Table S 1) for their survival phenotype on both pathogens. While nine clec mutant strains 
exhibited a susceptibility phenotype on BT and four clec mutants on PA14, seven clec mutant strains 
showed a resistance phenotype on BT and six clec mutants on PA14 (Figure 1; Table S 2, Table S 3). 
Except for clec-90(tm3402), none of the clec mutant strains showed a significant survival phenotype on 
the non-pathogenic treatment controls, E. coli OP50 or BT407 (data not shown). We could confirm the 
results of the first screen for most of the clec mutants, which had shown significantly altered 
susceptibility to infection, in a secondary screen with an increased number of replicates on PA14 (data 
not shown) and an additional concentration for BT (Figure S 1A; Table S 2, Table S 3). Considering the 
common assumption that C. elegans CTLD proteins are key players in the immune defense it is 
somewhat surprising that 18% of the here tested clec mutants on BT and 16% of the clec mutants on 
PA14 showed an increased resistance phenotype. The genetic manipulation of clec genes by RNAi 
knock-down has been previously shown to affect worm survival after pathogen exposure17–20. Using 
knock-out mutants Miltsch and colleagues found a higher susceptibility on Serratia marcescens for 
clec-49(ok2416) and clec-39(ok2271)20, whereas the latter has shown to be more resistant on PA14 in 
our screen (Figure 1B). Given the fact that S. marcescens and PA14 are both Gram-negative bacteria 
the contrary survival phenotypes of the clec-39 mutant might hint to a species-specific role in regulating 
the immune response, as previously proposed13. However, to the best of our knowledge it has never been 
reported before that C. elegans clec mutants are resistant to infection. Our results suggest that C. elegans 
CTLD proteins can mediate suppression of the immune response. For vertebrate C-type lectin receptors 
it is known that they play activatory as well as inhibitory roles in regulating the immune responses, one 
example is the inhibitory receptor Clec12a29,30. 
 52 
 
Figure 1: Survival screen of C. elegans clec mutants upon exposure to pathogenic (A) BT18247 and (B) PA14. 
The two different shades of red represent different concentrations (conc) of BT mixed with E. coli OP50. The 
proportional survival was scored (A) 24 hpi or (B) 72 hpi and normalized by the wild type control N2 (x = 1, vertical 
dashed line). Values < 1 indicate more susceptible, values > 1 more resistant strains. Means of three replicates 
are shown; the error bars are the standard error (SE) of the mean. Significant differences were determined with 
a randomization test49, corrected for multiple comparisons with false discovery rate (FDR)50 and denoted by 
asterisks (*P < 0.025, **P < 0.005, ***P < 0.0005). Note that the x-axes are log10 and log2 transformed, 
respectively. 
 
Increased resistance of clec mutants correlates with escape behavior. 
During our initial survival screen of the 39 clec mutants, we noticed for some of the clec mutants that a 
noticeable fraction was missing on BT at 24 hpi, the time point of scoring. As BT is known to induce 
behavioral pathogen avoidance responses in C. elegans31 and as increased pathogen avoidance behavior 
can lead to increased resistance to infection32, we examined if we could observe this phenomenon in the 
clec mutants of our screen. Therefore, we plotted the survival rate against the number of missing worms 
(“leaving index”) and indeed, increased survival was positively correlated with increased leaving 
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(Figure S 1B). Thus, worms, which showed avoidance towards the pathogen, enhanced their chances of 
coping with the pathogenic threat. 
Pathogen avoidance behavior as natural strategy to escape infection has been described already for many 
other pathogens in C. elegans (e.g. 33–36). In an evolutionary context, evading potential harm is a highly 
efficient defense strategy found across the animal kingdom37, which is not as costly as mounting a 
physiological immune response38. Further, avoidance of contact with pathogens and thus infection also 
prevents tissue damage, which might arise not only from virulence mechanisms of the pathogen, but 
also from the host’s own immune effector mechanisms, such as the production of reactive oxygen 
species (ROS)39. 
C54G4.4 negatively regulates avoidance behavior towards pathogenic BT. 
Based on our observation that increased resistance was correlated with increased escape in our initial 
screen, we tested if the clec mutant with the strongest resistant phenotype on BT, C54G4.4(ok2110) 
(Figure 1A), showed high pathogen avoidance. The exposure to mild concentrations of pathogenic 
BT18247 caused the previously described pathogen avoidance behavior in both strains, the wild type 
and C54G4.4(ok2110) (for all comparisons P < 0.001 according to a generalized linear mixed model 
(GLMM)40, Bonferroni corrected41). Moreover, the C54G4.4(ok2110) mutant exhibited a much stronger 
behavioral avoidance response on the pathogen compared to the wild type (Figure 2A). These results 
thus confirmed our initial observation that the resistant C54G4.4(ok2110) mutant shows high avoidance 
behavior on BT. In addition, we validated the increased survival phenotype of the C54G4.4(ok2110) 
mutant on BT (Figure 2B) which conforms to the observed correlation between increased resistance and 
escape behavior in the screened clec mutants (Figure S 1B). In addition to strong avoidance behavior, 
an enhanced physiological immune response could underlie the high resistance of the C54G4.4 mutant 
on BT. To rule out the latter, we conducted another survival assay, in which all plates were fully covered 
with the bacterial lawn. This is a common approach to enforce an encounter of worms and pathogens 
and thus to analyze the contribution of the physiological immune response to resistance while worms 
cannot escape (e.g. 32). However, the C54G4.4(ok2110) mutant still managed to escape and most worms 
desiccated at the rim of the Petri dish, so that the results were not reliable (data not shown). Thus, we 
cannot entirely exclude the involvement of physiological immune mechanisms in C54G4.4’s resistance 
to BT, but our data strongly supports the importance of the behavioral response.  
We here present for the first time evidence for a role of a CTLD encoding gene, C54G4.4, in C. elegans 
pathogen avoidance behavior. The high avoidance behavior of the C54G4.4 mutant on BT indicates that 
C54G4.4 negatively regulates C. elegans behavioral immunity. This phenomenon is reminiscent of the 
microbial aversion behavior triggered in worms, in which cellular core processes are disrupted by 
RNAi42. However, this scenario can be ruled out here since the worms showed elevated avoidance only 
on the pathogen but not on the control (Figure 2A).  
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Figure 2. Immune behavior, survival phenotype and domain architecture of C54G4.4(ok2110) knock-out strain. 
(A) Avoidance behavior of C54G4.4(ok2110) compared to wild type over time. Each panel shows the applied 
bacterial treatment. Means  SE of five replicates are shown. Comparisons between both strains, P < 0.001 for 
each BT18247 treatment, generalized linear mixed model (GLMM)40, Bonferroni corrected41. (B) Survival of 
C54G4.4(ok2110) and wild type on a 1:2 dilution of BT407 and serial dilutions of BT18247 24 hpi. Means  SE of 
three replicates are shown. Comparison between both strains, P < 0.001, generalized linear model (GLM)48, 
Bonferroni corrected41. (C) Domain architecture adapted from SMART (http://smart.embl-heidelberg.de/) taking 
UniProt as source database. Numbers represent the amino acid position. (D) Pumping activity of 
C54G4.4(ok2110) and wild type on 1:100 dilutions of BT407 and BT18247 each mixed with E. coli OP50. Grinder 
movements (“pumps”) within 20 s of three individuals per replicate were scored. Mean  SE of three replicates 
are shown. Comparisons between both strains, P = 0.006 in BT18247 treatment at 24 hpi, GLM48, Bonferroni 
corrected41. 
 
C54G4.4 encodes a transmembrane CTLD protein and has, in addition to its CTLD, four extracellular 
Sushi domains (Figure 2C). Sushi domains are important protein-protein interaction domains occurring 
in proteins of the complement system, hence the alias complement control protein (CCP) module43, and 
C54G4.4 is orthologous to human complement factor H and complement component 4 binding protein. 
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According to expression data on WormBase (Version WB250), C54G4.4 is expressed in neurons, where 
it could act to mediate behavioral immune responses. We generated transgenic reporter strains carrying 
transcriptional C54G4.4::GFP fusion constructs to analyze C54G4.4 expression in vivo, but could 
unfortunately not detect any GFP signal, possibly due to low expression levels of C54G4.4. However, 
the C. elegans neuropeptide receptor gene npr-1 is an example of a gene expressed in neurons, which 
mediates resistance to PA14 through oxygen-dependent behavioral avoidance of the pathogen32.  
Which exact role C54G4.4 plays in mediating pathogen susceptibility and regulating avoidance behavior 
to BT and in which immune cascade its action is implemented remains to be elucidated. 
C54G4.4 negatively regulates feeding cessation on pathogenic BT. 
Another behavioral defense strategy in C. elegans is feeding cessation. Harmful microbes evoke a 
reduction in food uptake as reported for both BT24,31 and PA1427, and also other pathogens (e.g. 35,44,45). 
Exposure of worms to E. coli expressing one of the main virulence factors of BT, the Cry toxin Cry6Aa2, 
is sufficient to trigger feeding cessation46. A common approach to assess food up-take in C. elegans is 
to measure the movement of the grinder (“pumps”)47. We therefore observed the pumping activity of 
C54G4.4(ok2110) on mild concentrations of BT over time. As expected, in both, the C54G4.4(ok2110) 
mutant and wild type worms, the pumping activity was lower on pathogenic BT18247 compared to the 
non-pathogenic control (P < 0.001 according to a GLM48, Bonferroni corrected41). The wild type 
stopped feeding at an early time point after pathogen exposure (1 hpi), but resumed feeding at later time 
points (6 and 24 hpi). Interestingly, C54G4.4(ok2110) behaved similarly at 1 and 6 hpi, but then 
remained at a low feeding rate at 24 hpi (Figure 2D). This result suggests that not only increased 
avoidance behavior, but also prolonged feeding cessation contributes to the highly resistant survival 
phenotype of C54G4.4(ok2110) mutants. 
Conclusions 
With a systematic screen of 39 clec mutants for survival on the two pathogens BT18247 and PA14, we 
wanted to test the common assumption that clec genes function in C. elegans immunity. While our 
results indeed provide evidence for a role of clec genes in resistance, our data also suggest that clec 
genes function as negative regulators of immunity (Figure 1). We found that the resistance phenotype 
was positively correlated with the occurrence of missing worms, i.e. pathogen avoidance behavior 
(Figure S 1B). For one clec gene, C54G4.4 (Figure 2), we could confirm that the high resistance of the 
C54G4.4(ok2110) mutant is likely due to a high avoidance behavior on BT and also a prolonged 
reduction in feeding on the pathogen. We thus provide for the first time evidence for a role of a 
C. elegans clec gene in regulating immune behaviors.  
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Supplementary Tables and Figures 
Table S 1. Knock-out clec gene mutants provided by CGCa and NBRPb. 
strain affected gene genotype WormBase ID source 
 clec-1 clec-1(tm1291) WBGene00017772 NBRP 
RB1660 clec-4 clec-4(ok2050) II WBGene00012583 CGC 
 clec-13 clec-13(tm4129) WBGene00010399 NBRP 
 clec-15 clec-15(tm3833) WBGene00011584 NBRP 
RB2345 clec-29 clec-29(ok3181) V WBGene00012024 CGC 
RB1701 clec-34 clec-34(ok2120) V WBGene00012023 CGC 
 clec-38 clec-38(tm2035) WBGene00012025 NBRP 
RB1767 clec-39 clec-39(ok2271) V WBGene00012022 CGC 
RB2350 clec-43 clec-43(ok3188) II WBGene00019917 CGC 
RB1870 clec-49 clec-49(ok2416) V WBGene00012251 CGC 
RB1897 clec-50c clec-50(ok2455) V WBGene00012253 CGC 
RB1898 clec-50d clec-50(ok2456) V WBGene00012253 CGC 
 clec-60 clec-60(tm2319) WBGene00014046 NBRP 
RB2004 clec-63 clec-63(ok2656) II WBGene00009394 CGC 
RB2121 clec-64 F35C5.7(ok2806) II WBGene00009395 CGC 
RB1803 clec-65 clec-65(ok2337) II WBGene00009396 CGC 
RB1745 clec-66 clec-66(ok2230) II WBGene00009397 CGC 













 clec-90 clec-90(tm3402) WBGene00019009 NBRP 
VC1600 clec-98 ZK39.7(ok2085) I WBGene00013932 CGC 
RB1403 clec-104 Y18D10A.10(ok1596) I WBGene00012480 CGC 





 clec-108 clec-108(tm1622) WBGene00012504 NBRP 





RB2217 clec-175 R08C7.6(ok2999) IV WBGene00019950 CGC 
VC2919 clec-198 
clec-198(gk3149) IV;  
W03G11.3(gk1251) X 
WBGene00008203 CGC 
RB1984 clec-227 clec-227(ok2618) V WBGene00008593 CGC 
RB2308 clec-230e C29F3.5(ok3131) V WBGene00007806 CGC 
RB2326 clec-230f clec-230(ok3158) V WBGene00007806 CGC 
VC2185 C06B8.7 C06B8.7(ok2814) V WBGene00007372 CGC 
RB1697 C54G4.4 C54G4.4(ok2110) I WBGene00008314 CGC 





 egas-4 F55G1.13(tm4826) WBGene00018906 NBRP 
VC158 lat-2 lat-2(ok301) II WBGene00002252 CGC 
  T25C12.3 T25C12.3(tm4691) WBGene00012018 NBRP 
a Caenorhabditis Genetics Center, Minnesota, USA.  d Denoted as clec-50_B in Figure 1.  
b National BioResource Project, Tokyo, Japan.  e Denoted as clec-230_A in Figure 1. 
c Denoted as clec-50_A in Figure 1.   f Denoted as clec-230_B in Figure 1. 
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Table S 2. P values of clec gene mutant screen on BT18247 according to randomization test (Figure 1 A). 
mutant strain BT conca P corrected P validatedb remark 
clec-15 1:50 0.0027 0.0222 yes   
clec-29 1:50 < 0.0005 0.0022 yes confirmed after out-crossing 
clec-34 1:50 < 0.0005 0.0039 yes confirmed after out-crossing 
clec-38 1:50 0.0015 0.0156 yes  
clec-43 
1:50 < 0.0005 0.0022 
yes lost phenotype after out-crossing 
1:100 0.0027 0.0222 
clec-50_B 1:50 < 0.0005 < 0.0005 no  
clec-64 1:50 < 0.0005 0.0062 yes  
clec-90 
1:50 < 0.0005 0.0022 
yes 
 
1:100 0.0006 0.0085  
clec-104 1:50 < 0.0005 0.0052 yes  
clec-108 1:50 < 0.0005 < 0.0005 yes lost phenotype after out-crossing 
clec-151 1:50 < 0.0005 < 0.0005 yes confirmed after out-crossing 
clec-198 
1:50 0.0021 0.0193 
yes 
 
1:100 0.0018 0.0176  
clec-227 1:50 0.0011 0.0132 yes lost phenotype after out-crossing 
clec-230_A 1:50 0.0015 0.0156 yes  
C54G4.4 1:50 < 0.0005 < 0.0005 yes validated in Figure 2B 
T25C12.3 1:50 0.0010 0.0130 yes lost phenotype after out-crossing 
a conc, concentration. 
b Mutant strains, which included in validation of initial screen (Figure S 1A). 
 
Table S 3. P values of clec gene mutant screen on PA14 according to randomization test (Figure 1B). 
mutant strain P corrected P validateda remark 
clec-34 0.0023 0.0167 no  
clec-39 0.0010 0.0123 yes lost phenotype after out-crossing 
clec-43 < 0.0005 0.0064 yes lost phenotype after out-crossing 
clec-50_A < 0.0005 0.0063 no  
clec-60 0.0023 0.0167 no  
clec-90 < 0.0005 0.0063 yes susceptibility also on OP50 control 
clec-151 < 0.0005 0.0022 yes  
clec-155 < 0.0005 0.0063 yes  
cwp-5 0.0018 0.0163 no  
T25C12.3 0.0018 0.0163 no   




Figure S 1. Validation of mutant screen on BT and positive Pearson’s correlation between survival and 
avoidance behavior. (A) clec mutants that showed significant alterations in survival – in the first screen on BT 
(Figure 1A) were retested on three different concentrations of BT mixed with E. coli OP50. Each dot represents 
the resulting mean of five replicates colored according to their survival phenotype in the first screen. The error 
bars represent the means of group “resistant” or “susceptible”  SE per BT concentration. Wilcoxon rank sum 
test51 between survival phenotype groups per BT concentration, FDR corrected50; P = 0.001 for 1:100, P = 0.003 
for 1:50, P = 0.01 for 1:10. (B) Correlated are the means of proportion alive as shown in Figure 1 and the means 
of the leaving index ((initial total number of worms - present worms 24 hpi)/initial total number of worms), both 
normalized by the control values of N2. The two different shades of red represent different concentrations (conc) 
of BT mixed with E. coli OP50; the open circles represent data of the C54G4.4(ok2110) mutant. Note that both 
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Despite the increasing understanding of the innate immune system of the nematode Caenorhabditis 
elegans certain aspects of its immunity, such as pathogen recognition and clearance still need to be 
determined. The study of the highly diverse C. elegans gene family encoding C-type lectin-like domain 
(CTLD) proteins (clec genes) has the potential to close these knowledge gaps, as clec genes might 
function in both pathogen recognition and clearance. A role of C. elegans clec genes in immunity has 
indeed been repeatedly suggested and in some cases even been taken for granted, although their exact 
function is completely unknown. Using WormExp, a recently established database for C. elegans gene 
expression analysis, we analyzed microbe- and stress-induced expression of clec genes and identified 
clec-4 as being highly responsive to infection with different pathogens and exposure to several stressors. 
We selected the clec-4 gene for subsequent functional analyses at the gene and protein level. Contrary 
to our expectations, clec-4(ok2050) mutants were more resistant to infection with pathogenic Bacillus 
thuringiensis than wild type worms and did not show a survival phenotype on Pseudomonas aeruginosa. 
By looking at expression of clec-4 paralogs, we identified clec-41, which is mainly co-expressed with 
clec-4, and clec-10, which is differentially regulated in the opposite direction from clec-4. Silencing 
clec-41 and clec-10 expression by RNAi led to increased susceptibility to BT infection in wild type 
worms and suppression of the resistance phenotype in clec-4 mutants. On the protein level, we tested 
binding of the recombinantly expressed CLEC-4 protein to different bacterial species and one yeast 
species and found that CLEC-4 binds to a pathogenic and non-pathogenic BT as well as yeast in a 
calcium-dependent manner. Together, our data suggest that clec-4 functions in the negative regulation 
of the C. elegans immune response to BT infection and genetically interacts with its paralogs clec-41 
and clec-10. The binding activity of CLEC-4 towards BT reinforces the notion of clec-4 playing a role 




Like all invertebrates the nematode Caenorhabditis elegans solely relies on innate immunity. Yet, highly 
sophisticated physiological mechanisms aid the worm to persist in its microbe-rich environment, which 
is full of potential pathogens1. These mechanisms can generally be divided into three modules: (i) Direct 
and indirect recognition of pathogens and initiation of downstream signaling is mediated by pattern 
recognition receptors (PRRs), of which, however, only two have been discovered in C. elegans – the 
RIG-1-like helicase DHR-1 recognizes viral RNA and triggers the RNAi cascade2, and the G protein-
coupled receptor (GPCR) DCAR-1 binds the endogenous, putative damage-associated molecular pattern 
(DAMP) 4-hydroxyphenyllactic acid (HPLA) and activates expression of the antimicrobial peptide 
nlp-29 in the epidermis3. (ii) Transmission of the immune response by evolutionary conserved signaling 
pathways, with the p38 MAPK cascade being one of the central pathways, acting in both the epidermis 
and the intestine4,5. (iii) Finally the expression of antimicrobial peptides such as lysozymes (lys, ilys), 
caenopores (spp), or members of the neuropeptide-like protein (nlp) family (reviewed in 6,7) and 
elimination of the pathogen. Nevertheless, one of the major knowledge gaps in our understanding of 
C. elegans immunity concerns the question of how the host discriminates between bacterial pathogens 
and commensals or food bacteria and what are the exact triggers inducing the immune response. 
The study of one protein family in C. elegans could help to shed light on these constantly recurring 
questions – the C-type lectin-like domain (CTLD) proteins. Due to their essential, well described role 
in recognition and activation of the vertebrate immune response to fungal infection, C. elegans CTLD 
proteins have repeatedly been considered to be involved in immunity, although experimental evidence 
supporting this idea remains scarce. The CTLD proteins are characterized by a conserved carbohydrate-
recognition domain (CRD), with which sugar can be bound in a calcium-dependent (C-type) manner. 
But not all of the proteins carrying a CRD bind glycans and/or require calcium for binding, which is 
why we will use the more general term CTLD proteins in the following, as previously suggested8. In 
vertebrates CTLD proteins occupy important immune functions, acting mainly as classical PRRs 
binding ligands derived from fungi, bacteria or viruses, and as dead and cancerous cell sensors 
enhancing tumor killing activities of natural killer cells (reviewed in 9). Some CTLD proteins that seem 
to play a role in immune defense have also been characterized in invertebrates, especially in 
economically important crustaceans and in insects. Yet, their exact immune functions are far from being 
completely understood (reviewed in 10). 
C. elegans stands out for its highly diversified CTLD encoding gene (clec) repertoire (reviewed in 10). 
283 CTLD proteins are encoded in the nematode’s genome with half of them carrying an additional 
CTLD or other domains such as CUB (Complement C1r/C1s Uegf Bmp1), CW (conserved cysteine and 
tryptophan residues), or VWA (Von Willebrand factor type A)7. Several C. elegans transcriptome 
analyses revealed that the majority of the clec genes are highly up-regulated upon pathogen exposure 
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and this (e.g. 11–13) in a highly specific pattern7. By reverse genetic analyses some clec genes were shown 
to be required for defense against infection with certain pathogens, e.g. clec-17, -60, and -86 for 
Microbacterium nematophilum14, clec-70 for Staphylococcus aureus15, clec-65 for the pathogenic 
Escherichia coli strain LF8216, or clec-174 for Vibrio cholerae17. On the protein level, only two CLEC 
proteins were demonstrated to bind bacteria in vitro: CLEC-39 and CLEC-40 bind to dead and alive 
Serratia marcescens18. 
In this study we thus aimed at understanding in how far pathogen-responsive clec genes really function 
in C. elegans immunity. Thus, we employed a recently established database for C. elegans gene 
expression analysis, WormExp19, and analyzed the expression of clec genes after exposure to pathogens 
and stress. We found one clec gene, clec-4, to be highly up-regulated upon infection with many 
pathogens and exposure to several stressors. Here we show that the clec-4(ok2050) mutant is resistant 
to infection with the Gram-positive Bacillus thuringiensis (BT), suggesting a role of clec-4 in immune 
suppression. Further, we attempt to disentangle the much discussed issue of functional redundancy 
within the clec family by analyzing clec-4 interaction with two of its paralogs, clec-10 and clec-41. 
Knocking-down clec-41 or clec-10 expression by RNAi results in higher susceptibility to BT in wild 
type worms and suppresses the resistance phenotype in clec-4 mutants, suggesting opposing roles in 
modulation of immunity. Moreover and most importantly, we started to examine the function of CLEC-4 
on the protein level by testing the binding activity of the recombinant protein in vitro. 
To summarize, these results suggest a negative regulatory role of clec-4 in immunity against BT and 
give a glimpse at a complex regulation network involving different clec genes. Further studies are 
needed for a more detailed understanding of clec-4/CLEC-4 function on both the gene and protein level. 
Materials and Methods 
Meta-Analysis of Transcriptional Response 
The information on clec-4 paralogs were downloaded from WormBase Version WS250 
(http://www.wormbase.org)20, gene expression data sets from the two categories “Microbes” 
(pathogens) and “Chemicals/stress” were analyzed using WormExp (http://wormexp.zoologie.uni-
kiel.de/wormexp/)19. The heat map only shows the data sets, in which clec-4 was differentially expressed 
(Figure 1A). 
Strains and Culture Conditions 
Worms were grown and maintained on NGM agar plates seeded with Escherichia coli OP50 as 
previously described21. The wild type strain N2 (Bristol) and the mutant strain RB1660 carrying the 
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clec-4(2050) allele were ordered at the Caenorhabditis Genetics Center (CGC, Minnesota, USA), the 
latter back-crossed 3x with N2 prior to use. 
Bacillus thuringiensis strains MY-BT18247 (in the following BT18247) and BT407 were originally 
obtained from the Agriculture Research Service Patent Culture Collection of Microorganisms and Cell 
Cultures (United States Department of Agriculture, Peoria, Illinois, USA). Spore-toxin mixtures were 
generated following previous protocols22–24 and frozen at -20 °C in aliquots with a spore concentration 
ranging from 3*109 to 8*109 particles/ml, depending on the culture, for BT18247 and 
1.1*1010 particles/ml for BT407. Stocks were thawed and then immediately applied in 
survival/avoidance assays. Pseudomonas aeruginosa strain PA14 (provided by Dennis Kim) was grown 
first on LB plates and then in LB broth at 37 °C overnight prior to inoculation of assay plates. 
Generation of Transgenic Strains 
The pclec-4::GFP reporter construct was generated by PCR fusion as previously described25. The clec-4 
promotor (~1.2 kb upstream of start codon) was amplified from genomic DNA by PCR with primer A 
(5'-ACCAGAAGCCGAGAATCCAC-3') and primer B (5'-AGTCGACCTGCAGGCATGCAAGCT 
GGCTCTTTTATT CGCAATTTCCAT-3', with bold letters being the overlapping sequence to the gfp 
vector). The gfp coding sequence plus the 3'-UTR of unc-54 was amplified from the Fire vector 
pPD95.75 with primer C (5'-AGCTTGCATGCCTGCAGGTCGACT-3') and D (5'-AAGGGCCCGTA 
CGGCCGACTAGTAGG-3'). The transgenic construct pclec-4::GFP was finally synthesized using PCR 
fusion with primer A* (5'-TTTGAAATTCCACCACTGTTCCCAC-3') and D* (GGAAACAGTT 
ATGTTTGGTATATTGGG) and directly injected at a concentration of 10 ng/µl. The co-injection 
marker pttx-3::RFP, which is expressed in the AIY interneuron pair of successfully transformed animals, 
was used at a concentration of 40 ng/µl. Of four generated transgenic lines, MY1031 yaEx26 was further 
analyzed by microscopy. All pictures were taken with the confocal microscope LSM 700 by Zeiss (Carl 
Zeiss AG, Jena, Germany). 
Survival and Avoidance Assays 
PFM agar plates (6 cm diameter) were inoculated with 75 µl of a mixture of BT and E. coli OP50 at 
OD 5 at different concentrations. The survival plates were kept at 20 °C overnight. PA14 required 
enriched NGM (0.35% instead of 0.25 % peptone) for efficient killing of worms. Seeded with a mixture 
of PA14 (OD 1) and E. coli OP50 (OD 5) at a concentration of 1:3 plates were incubated for 24 h at 
37 °C and another 24 h at 25 °C, the temperature, at which the PA14 survival assay was conducted. 
Plates seeded solely with E. coli OP50 or non-pathogenic BT407 were used as controls in BT survival 
assays, and E. coli OP50 plates in survival assays with PA14. 30 synchronized L4 larvae were picked 
onto each plate and worm survival was scored once after 24 h (BT) or every day until all worms on the 
pathogen were dead (PA14). Worms were considered to be dead if they did not respond to light touch. 
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For scoring the avoidance behavior the appropriate media plates (9 cm diameter) were prepared as 
described above for the survival assays but with a 30 µl spot of the bacterial mixture in the middle. For 
BT exposure mild concentrations were chosen in order to challenge but not to kill the worms. Ten 
previously synchronized L4 hermaphrodites were picked onto each bacterial spot in the middle of the 
plate at time point 0 hpi (hours post infection) and the worms residing on that spot were scored every 
second hour. The leaving index was calculated as follows: (total number of worms - worms on bacterial 
spot)/total number of worms. Dead individuals were excluded from the total number of worms per plate. 
Protein Binding Assays 
Protein CLEC-4 with an N-terminal His tag was commercially obtained from GenScript 
(http://www.genscript.com/, Piscataway, New Jersey, USA); it was expressed in E. coli BL21 (DE3) 
with vector E3, purified, refolded and confirmed by SDS-PAGE and Western blot using Mouse-anti-
His mAb. The recombinant protein was stored at -80 °C in TBS buffer (50 mM Tris-HCl, 150 mM NaCl, 
pH 7.6) with 10% glycerol. Bacteria were grown at 37 °C overnight in LB (yeast in YPD), pelleted, 
washed, and resuspended in TBS buffer with or without CaCl2 (10 mM final concentration) at OD 2. 
The bacterial solution with 10 µg of the recombinant CLEC-4 was incubated in 50 µl of total volume 
for 30 min at room temperature. After taking out 16 µl “total” sample (T) the reaction mixtures were 
centrifuged at 6000 g at 4 °C for 5 min, the “supernatant” sample (S) was taken off, and the remaining 
“pellet” sample (P) resuspended in 16 µl fresh TBS buffer. All samples were boiled for 5 min mixed 
with Laemmli sample buffer26 and subjected to 12% SDS-PAGE including subsequent analysis by 
Coomassie Brilliant Blue (CBB) staining. 
Statistical Analyses 
Statistical analyses were done with RStudio (Version 0.98.977), graphs created with its package ggplot2 
(Version 0.9.3.1) and edited with Inkscape (Version 0.48). 
Results and Discussion 
Expression of clec-4 is highly up-regulated upon pathogen exposure and 
stress. 
One of the main reasons why C. elegans clec genes have repeatedly been suggested to be involved in 
immune responses is that clec genes are always among the genes that are highly up-regulated by 
pathogen infection and also stress. The repertoire of induced clec genes differs from pathogen to 
pathogen, suggesting a highly specific regulation (reviewed in 10). However, the expression of few clec 
genes is activated by infection with several pathogens, indicating a more general role in C. elegans 
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immunity. As we were interested in testing the potential immune function of C. elegans clec genes, we 
performed a transcriptome meta-analysis using WormExp, a recently established database for C. elegans 
gene expression analyses19. We looked at the pathogen (microbe)- and stress-dependent expression 
pattern of clec genes and identified clec-4 as one of the clec genes, which is highly up-regulated upon 
infection with a broad array of pathogens and several stressors (Figure 1A).  
 
 
Figure 1. Pathogen- and stress-dependent expression pattern of clec-4 and a subset of its paralogs and in vivo 
expression of a pclec-4::GFP reporter. (A) Heat map showing the differential expression of clec-4 and its paralogs 
in worms exposed to different pathogens and stressors. Note that one BT column is based on proteome data 
(prot.). Twelve clec-4 paralogs, which did not exhibit a differential expression have been excluded. Genes are 
organized by hierarchical clustering from Cluster 3.030. Red and blue colors indicate up- and down-regulation, 
respectively. Transcriptomic data taken from 12,17,27,28,31–34 were analyzed using WormExp19. (B) The pclec-4::GFP 
reporter is constitutively expressed throughout the intestine in the embryo and at all larval stages and most 
strongly in int1 and the posterior intestine in adults. The co-injection marker pttx-3::RFP is expressed in the AIY 




Interestingly, in the case of infection with the Gram-positive Bacillus thuringiensis Treitz et al. could 
demonstrate in a quantitative proteome analysis that the abundance of the CLEC-4 protein indeed highly 
increased (highest observed protein ratio)27,28. In addition to that, clec-4 up-regulation after infection 
with PA14 was confirmed by qRT-PCR29. The broad transcriptional response to a variety of pathogens 
and stressors suggests that clec-4 is part of a more general defense response. Taken all these observations 
together, clec-4 represents a promising clec candidate gene to analyze in more detail. 
A pclec-4::GFP reporter is constitutively expressed in the intestine. 
In order to visualize the expression pattern of clec-4 in vivo we generated a transcriptional reporter 
fusing the clec-4 promoter to the green fluorescent protein (GFP). The reporter showed highly 
constitutive expression of pclec-4::GFP in the intestine throughout all stages. Expression seems to be 
decreased in adults, in which a strong GFP signal could only be observed in the most anterior and 
posterior cells of the intestine (Figure 1B). Intestinal expression of several other C. elegans clec genes 
has been reported before (14,15,35 and unpublished data from our group). Given the fact that most bacterial 
pathogens are taken up orally by the worm and establish intestinal infections, the intestinal expression 
of clec-4 is in line with its potential immune function. In contrast to the analyzed transcriptome data, an 
infection with pathogenic BT or PA14 did not enhance the expression of our transcriptional reporter. 
This might be due to the fact that the constitutive expression of pclec-4::GFP is already so strong that a 
further up-regulation of the fluorescent reporter is not discernable by eye. An analysis of the available 
C. elegans transcriptome data indeed showed that clec-4 is expressed also on non-pathogenic bacteria 
(data not shown).  
pclec-4::GFP is expressed in amphid neurons, but clec-4 is not required for 
pathogen avoidance behavior. 
Intriguingly, clec-4 is also constitutively expressed in the amphid neurons from the first larval stage to 
the adult (Figure 1C). Neuronal expression of putative antimicrobial genes in the head has been reported 
in C. elegans before, e.g. for lysozymes lys-1, lys-2 and lys-836, as well as for genes encoding 
antimicrobially active caenopores, spp-3 and spp-1237,38. These are interesting observations, as the 
C. elegans amphid neurons are chemosensory and thermosensory neurons with openings to the exterior 
that are generally known to be implemented in detecting microbial cues (important for food foraging 
and lawn-leaving behavior) or mating behavior, but also pathogen avoidance behavior39. It is thus 
intriguing to speculate that clec-4 functions in amphid neurons to bind bacterial components and mediate 
avoidance behavior. Consequently, we tested the clec-4(ok2050) mutant for its avoidance behavior on 
BT, but could not detect any difference to the behavior of wild type worms (Figure S 1). Still, clec-4 
might mediate the physiological immune response via the neuronal network (see below). 
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clec-4 knock-out confers resistance to BT. 
Expression of clec-4 is highly up-regulated by infection with Gram-negative PA14 and Gram-positive 
BT. For the latter this up-regulation on the transcriptional level was confirmed with higher CLEC-4 
abundance on the protein level28. We thus chose these two pathogens and did functional genetic analyses 
to test if clec-4 is indeed required for C. elegans resistance to infection. While the clec-4(ok2050) mutant 
was more resistant than wild type worms to BT infection (Figure 2A), there was no difference in survival 
on PA14 (Figure S 2). These findings were unexpected, since the strong induction of clec-4 gene 
expression upon pathogen exposure indicates an important role in pathogen defense, as has been 
recurrently suggested or taken for granted in the literature. 
The unexpected resistance phenotype of clec-4(ok2050) might have four alternative explanations: 
(i) clec-4 might be required for cellular core processes that are strictly monitored. If these processes are 
disturbed, i.e. lack of one component as in the knock-out mutant, surveillance pathways up-regulate 
general physiological and behavioral immune responses40. (ii) clec-4 might mediate susceptibility to 
infection through negatively regulating pathogen avoidance behavior, as was shown for another 
C. elegans clec gene, C54G4.4 (Pees et al., unpublished)41. (iii) clec-4 might encode a host factor, which 
is required for BT to successfully infect. For instance, binding of certain BT toxins to intestinal cells 
depends on C. elegans glycolipid receptors42. (iv) clec-4 might modulate immune defenses negatively, 
e.g. through down-regulation of immune genes. We can exclude the first two explanations as the 
clec-4(ok2050) mutants (i) exhibited normal (and not enhanced) survival and avoidance behavior on 
non-pathogenic BT407 compared to wild type worms, and (ii) did not show increased pathogen 
avoidance behavior on pathogenic BT (Figure S 1). Although we cannot exclude that clec-4 encodes a 
host factor required for successful infection, we hypothesize that clec-4 plays a role in suppressing the 
immune system. As clec-4 is also expressed in amphid neurons, it could play a role in the neuronal 
regulation of the C. elegans immune response, as it was shown for the G protein-coupled receptor gene 
octr-1 or the insulin-like peptide INS-7. The octopamine receptor OCTR-1 is expressed in the amphid 
neurons and while it is not required for pathogen avoidance behavior, it suppresses the physiological 
immune defense towards PA14 in non-neuronal tissues43. The insulin-like peptide INS-7 is expressed in 
neurons, but modulates the immune response to infection with PA14 via activation of the insulin/insulin-
like growth factor receptor (ILR) DAF-2 in the intestine44. In mammals, one CTLD protein that act as 
immune repressor has also been reported: Clec12a binds uric acid crystals and suppresses the respiratory 
burst thus preventing hyper-inflammation in mice45. This inhibitory CTLD protein is a transmembrane 
receptor with an intracellular ITIM (immunoreceptor tyrosine-based inhibitory motif) domain that 
mediates negative regulation of immune signaling and thereby counteracts activatory receptors. clec-4, 
however, lacks such a motif and contains a signal peptide and is therefore predicted to be secreted, 
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suggesting a different mechanism in negative regulation of immunity. The exact role and mechanism of 
clec-4 action in this context remains to be further elucidated.  
The lack of a survival phenotype of the clec-4 mutant on PA14 is somewhat less surprising as Miltsch 
et al. showed that the clec-4(ok2050) mutant was as resistant as wild type worms on Serratia 
marcescens18. Absence of a phenotype might be due to genetic or functional redundancy between the 
numerous clec genes in C. elegans (see further below).  
clec-41 and clec-10 RNAi suppress clec-4 resistance phenotype. 
The C. elegans genome consists of a remarkable repertoire of protein-encoding gene families situated 
in clusters of duplicated genes, one family being the clec genes46. The duplication rate of C. elegans 
exceeds the one of comparable model organisms, such as Drosophila melanogaster tenfold47. 
Consequently, almost one third of the genome encodes genes with one or more paralogs. These clustered 
genes or genetic duplicates might function analogously to the original gene48. 
As clec-4 is located directly upstream of its paralog clec-8, we wanted to test if there is functional 
redundancy between the two genes. We thus knocked down clec-8 expression by RNAi in the loss-of-
function mutant clec-4(ok2050) and again tested survival on BT. While the clec-4 mutant was clearly 
more resistant to BT infection than the wild type, hence confirming our previous results, silencing clec-8 
expression did not have an effect on survival, neither in the clec-4 mutant, nor in wild type worms. 
(Figure 2B). This indicates that clec-8 is neither required for, nor does it function redundantly to clec-4 
in the defense against BT. 
In addition to clec-8, clec-4 has 38 paralogs in C. elegans (WormBase Version WS250). Since paralogs 
of genes are considered to possess overlapping functions49 and since co-expressed genes are predicted 
to have similar function or to be involved in the same cellular process, we examined the pathogen- and 
stress-induced expression of these 39 clec-4 paralogs to identify co-expressed genes (Figure 1A). The 
expression of the gene clec-41 was induced like clec-4 in seven of eleven data sets, in case of BT 
infection at both the transcriptome and proteome level27,28. In contrast, the expression of clec-10 was 
regulated in the opposite way to clec-4 in five of the eleven data sets. 
To analyze genetic interaction between clec-4 and clec-41 and clec-10, we did a BT survival assay using 
RNAi to silence clec-41 or clec-10 expression in the clec-4 mutant and wild type worms. In contrast to 
the resistance phenotype of the clec-4(ok2050) mutant, clec-41 RNAi-treated worms were highly 
susceptible to BT infection. Unexpectedly, silencing clec-41 expression in clec-4(ok2050) mutants 
suppressed the resistance phenotype of clec-4(ok2050) to the level of wild type worm survival 
(Figure 2C). This result shows that clec-4 and clec-41 interact genetically with opposing effects on the 
immune response to BT infection. Comparable results were reported e.g. for the p38 MAPK/JNK 
pathway cross-talk. The MAPKK MEK-1 is required for a full activation of the p38 MAPK PMK-1, 
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while the MAPK phosphatase VHP-1 negatively regulates PMK-1 leading to susceptibility of mek-
1(ks54) mutants and resistance of vhp-1 RNAi-treated worms on PA14. mek-1(ks54);vhp-1(RNAi) 
worms exhibit the same survival phenotype as wild type worms50. Considering this as an example for a 
scenario, in which two genes play opposing roles in regulating the immune response and taking the 
transcriptome/proteome data into account, we hypothesize that clec-41 acts as a positive, while clec-4 
functions as a negative regulator of the response to BT infection. 
In the context of BT infection, clec-4 and clec-41 thus do not function redundantly, since clec-41 RNAi 
caused an opposite phenotype to clec-4(ok2050)51.  
 
 
Figure 2. (A) Survival of clec-4(ok2050) mutant and (B-D) effect of clec-8, clec-41, and clec-10 RNAi on survival 
of clec-4(ok2050) and wild type worms on BT. Worm strains were exposed to non-pathogenic BT407 and serial 
dilutions of pathogenic BT18247. Means  SD of five replicates are shown. Significant differences compared 
against wild type worms on BT18247 were determined by a generalized linear model (GLM)52, P values corrected 
for multiple comparisons with Bonferroni53 and denoted with ***P < 0.001 in the figure legend. 
 
Surprisingly, silencing the expression of clec-10, which showed an opposite regulation to clec-4, also 
resulted in higher susceptibility to BT infection (Figure 1A, Figure 2D), similarly to clec-41 RNAi, 
albeit the susceptibility phenotype was not as prominent. The down-regulation of genes during an 
infection usually suggests their participation in non-immune stress responses like metabolic processes14. 
Therefore, clec-10, whose expression is down-regulated on pathogenic BT and also on PA1413 might 
act in digestion, yet, at the same time be required for a proper recovery during and after pathogenic 
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attack. Understanding the exact role of clec-10 in the response to BT and its interaction with clec-4 
requires further investigation. 
CLEC-4 binds to BT and yeast, but not to E. coli OP50 and PA14. 
Most research on clec gene function in C. elegans is based on genetic manipulation and subsequent 
phenotypic analyses, while only two studies tackled functional analyses on the protein level. (i) Takeuchi 
et al. analyzed the sugar-binding activity for CLEC-7954 and (ii) Miltsch and colleagues demonstrated 
binding of CLEC-39 and CLEC-49 to S. marcescens18 in vitro. CTLD proteins are commonly considered 
to function as PRRs since the characterizing CRD is predestinated to recognize and bind glycans found 
on eukaryotic and prokaryotic cell membranes55. Soluble mannose-binding lectin (MBL), for example, 
is activated by microbe associated molecular patterns (MAMPs) such as mannose, fucose, and N-acetyl-
glucosamine, subsequently initiating the complement system in mammals56,57. CLEC-4 has two CTLDs 
and one CUB domain (Figure 3A) and might thus be involved in MAMP recognition by the CTLDs and 
immune system activation mediated by the CUB domain, which occurs for example in MBL-associated 
serine proteases (MASPs)58,59. Alternatively, secreted CTLD proteins might have antimicrobial effector 
protein functions like demonstrated for the antimicrobial members of the RegIII family60,61 or 
AmphiCTL1 in Amphioxus62. 
Hence, to investigate the function of CLEC-4 in C. elegans-pathogen interactions on the protein level, 
we performed bacterial binding assays with recombinantly expressed CLEC-4 and the bacterial species 
used in this study (E. coli OP50, BT407, BT18247, PA14) as well as one wild yeast isolate Pichia sp. 
(provided by Philipp Dirksen). The preliminary results of the binding assays indicate that CLEC-4 binds 
to non-pathogenic BT407, pathogenic BT18247, and yeast in a calcium-dependent fashion, but does not 
bind the Gram-negative food bacterium E. coli OP50 or PA14 (Figure 3B-F). 
Please note that these results are only preliminary as the binding assay requires further optimization. 






Figure 3. Domain architecture of CLEC-4 and SDS-PAGE of bacterial binding assays. (A) Domain architecture 
adapted from SMART (http://smart.embl-heidelberg.de/) taking UniProt as source database. Numbers represent 
the amino acid position. (B-F) SDS-PAGE showing bands of CLEC-4 upon incubation with different microbes in 
different fractions (T, total; S, supernatant; P, pellet) and with or without supplementation of Ca2+. Reaction 
buffer TBS without microorganisms was used for technical control of the assay (B right panels). While CLEC-4 did 
not precipitate in the pellet with E. coli bacteria (B left panels) or PA14 (E) after centrifugation, it did precipitate 
in the pellet with both BT strains, the non-pathogenic BT407 (C), the pathogenic BT18247 (D), and yeast (F). For 
more information see “Materials and Methods” section. 
Conclusion 
Here, we take first steps into the functional analysis of the CTLD protein encoding gene clec-4, which 
is highly up-regulated upon pathogen infection, on both the gene and protein level. We show that clec-4 
is expressed in the C. elegans intestine and amphid neurons. Phenotypic analyses of the clec-4(ok2050) 
mutant revealed that clec-4 negatively regulates the immune response to BT. We further identified the 
co- and contra-expressed clec-4 paralogs clec-41 and clec-10, respectively, which are both required for 
the immune defense against BT and interact with clec-4 genetically. Preliminary results of binding 
studies with the recombinantly expressed protein indicate that CLEC-4 binds to BT and yeast, but not 
to E. coli or PA. These first results raise many interesting research questions we would like to tackle in 
the near future (see Box 1). 
Heretofore, we conclude that it is not possible to infer a gene’s immune function purely from 
transcriptional data showing up-regulation upon pathogen exposure. CTLD gene expression in 
C. elegans shows an impressive response to pathogenic attack on the transcriptional level, however, 
experimental evidence of their involvement in immunity is scarce. Nevertheless, CTLD proteins remain 
an interesting family for the study of the evolution of innate immunity and the genetic interplay of an 





Box 1. Outstanding questions and future work. 
What is the evolutionary cost for the clec-4 mutants for being more resistant to BT? 
The fact that the clec-4 mutant exhibits higher survival after BT infection indicates that it negatively regulates 
the immune response. This raises the question whether the seemingly beneficial deletion comes with an 
evolutionary trade-off. A classic example for this in C. elegans is the long-lived knock-out mutant of the 
insulin-like receptor gene daf-2, which negatively regulates the FoxO transcription factor DAF-1663. The 
activation of DAF-16 due to the daf-2 knock-out leads to an increased resistance to pathogens and stresses64,65, 
but also causes slower development and a decrease in reproduction in non-challenging environments66. 
clec-4(ok2050) might therefore also show decreased evolutionary fitness, which can be tested with 
corresponding assays (e.g. brood size, reproduction rate, lifespan). 
Does clec-4 mediate susceptibility or resistance to infection with other pathogens? Can the missing 
survival phenotype of clec-4 on certain pathogens be explained by redundant paralogs? 
Our and previous results present a resistance phenotype of clec-4(ok2050) on BT18247, but no survival 
phenotype on PA14 or S. marcescens18. If not on BT, redundancy could be existent on PA14 or other pathogens. 
Therefore, exposing the knock-out mutant clec-4 alone or in combination with clec-41/clec-10 RNAi to other 
pathogen species (Gram-positive and -negativ) as well as other strains of BT that produce toxins different from 
BT18247 could give valuable information about the specificity of clec-mediated immune responses and 
redundant dependencies. The former might be even more exciting as the transcriptional response of clec-4 
displays a rather broad up-regulation against many pathogens and stressors. 
In vertebrates the recognition of fungus-derived components is covered particularly by C-type lectin receptors 
(e.g. Dectin-1 and -2 against Candida albicans67), which seduces to assume a similar role for CTLD proteins 
in C. elegans. Given the fact that in the wild the worm might encounter bacterial as well as fungal microbes68 
testing clec-4(ok2050) survival on different fungi would lead host-pathogen interactions in C. elegans into a 
whole other direction. 
In which tissue does clec-4 act to regulate C. elegans immunity?  
Analysis of the pclec-4::GFP reporter strain revealed that clec-4 is not only expressed in the intestine but also 
the amphid neurons. For defining the tissue, in which clec-4 functions to negatively regulate the immune 
response to BT infection, we plan to generate tissue-specific rescue and over-expression strains.  
Does clec-4 interact with known C. elegans immune signaling pathways? 
It is not well understood how the expression of clec-4 is regulated and if it acts up- or downstream of known 
immune signaling cascades. We thus would like to incorporate clec-4 into existing immune pathways in C. 
elegans. It was shown previously that clec-4 expression is under the control of the transcription factor ATFS-1, 
which functions in maintaining mitochondrial homeostasis during mitochondrial stress caused by PA14 
infection29, or of the GATA transcription factor ELT-2 upon BT infection (unpublished data from our group). 
Further, it is known for some other clec genes that they are regulated by the main C. elegans immune signaling 
pathways14,36,69. Potential genetic interactions of clec-4 with immune signaling pathway components will be 
tested by assessing survival of double-mutants, e.g. daf-2(e1370);clec-4(ok2050) or of clec-4 mutant worms, 
which are additionally treated with RNAi targeting different pathway components. In addition a role of known 
immune signaling components, e.g. tir-1 or pmk-1 of the p38 MAPK pathway, in regulating clec-4 expression 
will be examined with the help of the pclec-4::GFP reporter. 
Which microbes does CLEC-4 bind to and does CLEC-4 have antimicrobial activity? 
On the protein level, we could demonstrate that recombinant CLEC-4 seems to be able to bind to BT and yeast, 
but not to E. coli OP50 or PA14. The binding assay needs to be optimized and the results validated. 
Subsequently, different bacteria species could be tested in order to find binding specificity either on the species 
level or on a broader scale (e.g. Gram-negative vs. Gram-positive bacteria). As previously mentioned, CTLD 
proteins might also have antimicrobial activity. We will test if the recombinant CLEC-4 can act as antimicrobial 
protein by a variety of bacterial killing and inhibitory experiments in vitro (e.g. 62,70). Considering the natural 
habitat of C. elegans in microbe-rich environments fungal pathogens should be added to the microbial spectrum 
for protein activity tests (e.g. 71,72). Further, glucan arrays could assist to pinpoint the actual ligand of CLEC-4 
and might also answer the question of specificity (e.g. 73). 
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Figure S 1. Avoidance behavior of clec-4(ok2050) and wild type worms on BT. Worms were exposed to a mild 
concentration (1:400) of non-pathogenic BT407 and pathogenic BT18247. The avoidance index is defined as 
described in the “Materials and Methods” section. Means  SD of five replicates are shown. No significant 
differences between clec-4(ok2050) and wild type were determined by a generalized linear mixed model 
(GLMM)74 per bacterial treatment, P values corrected for multiple comparisons with Bonferroni53.  
 
 
Figure S 2. Survival of clec-4(ok2050) and wild type worms on E. coli OP50 and PA14. Means  SD of five 
replicates are shown. dpi, days post infection. No significant differences between clec-4(ok2050) and wild type 





The following figures and tables present additional data and analyses which either did not meet our 
expectations, did not answer our questions of interest, or are not sufficient for a complete manuscript. 
This chapter should fulfill the purpose of giving detailed information for further studies concerning 
clec/CLEC genes and proteins. 
 
 
Figure 1. Brood size screen of C. elegans clec mutants upon exposure to BT and E. coli OP50. clec mutants were 
screened for brood size in parallel to survival (see Chapter II for the complete list of mutants used). Five 
synchronized L4 larvae per plate were exposed to (A) low concentrations (conc) of pathogenic BT18247 mixed 
with E. coli OP50 at OD 5 (two shades of red) and (B) non-pathogenic BT407 in concentration 1:200 as well as 
E. coli OP50 at OD 5. All individuals were washed off 72 hpi (hours post infection) with M9 supplemented with 
0.1% Triton, frozen at -80 °C and the worm number was counted. The brood size was calculated as offspring per 
worm and normalized by the wild type control N2 (x = 1, vertical dashed line). Values < 1 indicate a lower brood 
size (less offspring per worm), values > 1 a higher brood size (more offspring per worm). Means of three replicates 
are shown; the error bars are the standard error (SE) of the mean. Significant differences were determined with 
a randomization test1 per bacterial treatment, corrected for multiple comparisons with false discovery rate 
(FDR)2 and denoted by asterisks (*P < 0.025, **P < 0.005, ***P < 0.0005). Note that the x-axes are log10 
transformed. All significant P values can be found in Table 1. 
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Table 1. Randomization test1 on brood size of clec mutants per bacterial treatment; P adjustment with FDR2. 
affected gene genotype strain treatment Figure P value significance level 
clec-227 clec-227(ok2618) V RB1984 BT18247, 1:200 1A < 0.0005 *** 
clec-98 ZK39.7(ok2085) I VC1600 BT18247, 1:200 1A < 0.0005 *** 
clec-227 clec-227(ok2618) V RB1984 BT18247, 1:300 1A < 0.0005 *** 
clec-67 F56D6.2(ok2770) IV RB2095 BT18247, 1:300 1A 0.0172 * 
clec-227 clec-227(ok2618) V RB1984 BT407 1B 0.0012 ** 
clec-50 clec-50(ok2455) V RB1897 BT407 1B 0.0020 ** 
clec-90 clec-90(tm3402)  BT407 1B 0.0118 * 
clec-29 clec-29(ok3181) V RB2345 E. coli OP50 1B 0.0016 ** 




Figure 2. Survival of out-crossed C. elegans clec mutants upon exposure to BT18247. Based on the results of 
the clec mutant survival screen (Chapter II), we chose the most promising clec gene candidates for out-crossing 
and further analysis: The clec-34 and clec-151 mutants were resistant on both BT and PA14. clec-49 and clec-50 
are in a cluster on chromosome V and seemed to mediate both resistance (clec-49) and susceptibility (clec-50) 
on BT and PA14. Due to technical reasons, we were not able to out-cross the clec-50 mutant and thus could not 
analyze it further. The clec-43 and T25C12.3 mutants were highly susceptible on both BT and PA14. The clec-108 
mutant was highly susceptible on BT. The clec-29 mutant was highly resistant on BT. As shown here after out-
crossing 3x with wild type N2 we could confirm the resistance phenotypes of clec-34, clec-49, clec-151, and 
clec-29 on BT, whereas we could not confirm the results for the other mutants. The assays were conducted with 
30 synchronized L4 larvae per plate exposed to pathogenic BT18247 mixed with E. coli OP50 at OD 5 in serial 
dilutions in PBS (x-axes). Alive and dead animals were scored 24 hpi. Worms were considered to be dead when 
they did not respond to light touch. BT407 was used as non-pathogenic control in the highest BT concentration 
applied for BT18247 per assay. For a detailed description see Chapter II, “Materials and Methods”. Survival was 
defined as proportion of alive individuals (y-axes) and is displayed as means  SE of five replicates. Significant 
differences were determined with a generalized linear model (GLM)3, always compared against the wild type per 
survival assay, and corrected for multiple comparisons with Bonferroni4. All P values can be found in Table 2. 
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Table 2. GLM3 on survival of clec mutants per survival assay; P adjustment with Bonferroni4. 
affected gene genotype strain Figure P value significance level 
clec-34 clec-34(ok2120) V RB1701 2A 0.021 * 
clec-49 clec-49(ok2416) V RB1870 2B < 0.001 *** 
clec-43 clec-43(ok3188) II RB2350 2C 1.000 n. s.a 
clec-108 clec-108(tm1622)  2C 1.000 n. s. 
clec-151 F10F2.7(ok2264) III RB1761 2D < 0.001 *** 
clec-29 clec-29(ok3181) V RB2345 2E < 0.001 *** 
clec-39 clec-39(ok2271) V RB1767 2E 0.345 n. s. 
T25C12.3 T25C12.3(tm4691)  2E 0.679 n. s. 
clec-227b clec-227(ok2618) V RB1984 not shown n. a.c n. s. 
a n. s., not significant. 
b The phenotypic analyses with the clec-227 mutant was performed by Marco Grasse; detailed information is to be found in his Master thesis.  




Figure 3. Survival assays of out-crossed C. elegans clec mutants upon exposure to PA14. Based on the results 
of the clec mutant survival screen (Chapter II), we chose the most promising clec gene candidates for out-crossing 
and further analysis: The clec-43 mutant was highly susceptible on both BT and PA14 and the clec-39 mutant was 
resistant on PA14. While we could not confirm the susceptibility phenotype of the clec-43 mutant on BT (see 
Figure 2C), we could confirm its susceptibility on short-term exposure to PA14 (A) and obtained contradictory 
results on a long-term exposure being more resistant (B). The resistance phenotype of the clec-39 mutant on 
PA14 was not confirmed. The assays were conducted at 25 °C with 30 synchronized L4 larvae (back-crossed 3x 
with wild type N2) per plate exposed to E. coli OP50 at OD 5 as non-pathogenic control or PA14 mixed with E. coli 
OP50 in dilution 1:3. Alive and dead animals were scored every day (dpi, days post infection). Worms were 
considered to be dead when they did not respond to light touch. For a detailed description see Chapter III, 
“Materials and Methods”. Survival was defined as proportion of alive individuals (y-axes) and is displayed as 
means  SE of five replicates. Significant differences were determined with Kaplan-Meier analysis5 and log-rank 
test6 per bacterial treatment and survival assay, and corrected for multiple comparisons with Bonferroni4. All P 
values can be found in Table 3. 
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Table 3. Kaplan-Meier analysis5 and log-rank test6 on survival of clec mutants per bacterial treatment; 
P adjustment with Bonferroni4. 
affected gene genotype strain treatment Figure P value significance level 
clec-39 clec-39(ok2271) V RB1767 E. coli OP50 3A n. a.a n.s.b 
clec-43 clec-43(ok3188) II RB2350 E. coli OP50 3A n. a. n.s. 
clec-39 clec-39(ok2271) V RB1767 PA14 3A n. a. n.s. 
clec-43 clec-43(ok3188) II RB2350 PA14 3A < 0.001 *** 
clec-43 clec-43(ok3188) II RB2350 E. coli OP50 3B 0.094 n.s. 
clec-43 clec-43(ok3188) II RB2350 PA14 3B 0.010 ** 
a n. a., not available. 




Figure 4. Survival of out-crossed clec-4 mutants and two transgenic rescue strains upon exposure to BT18247. 
Three transgenic rescue lines were generated, MY1066, MY1067, and MY1068, of which two were tested for 
their survival phenotype. For more information on the rescue lines please see Table 11. The assays were 
conducted with 30 synchronized L4 larvae per plate exposed to pathogenic BT18247 mixed with E. coli OP50 at 
OD 5 in serial dilutions in PBS (x-axes). Alive and dead animals were scored 24 hpi. Worms were considered to 
be dead when they did not respond to light touch. BT407 was used as non-pathogenic control in the highest BT 
concentration applied for BT18247 per assay. For a detailed description see Chapter II, “Materials and Methods”. 
Survival was defined as proportion of alive individuals (y-axes) and is displayed as means  SE of five replicates. 
Significant differences were determined with a GLM3 using Tukey contrasts7 as post-hoc test. All P values can be 
found in Table 4. 
 
Table 4. GLM3 and Tukey contrasts7 on survival of clec-4 and two transgenic rescue strains on BT. 
strain 1a genotype strain 2a genotype P value significance level 
clec-4 clec-4(ok2050) N2 wild type 0.013 * 
clec-4 clec-4(ok2050) MY1066c clec-4(ok2050);yaEx59 0.946 n. s.b 
clec-4 clec-4(ok2050) MY1068c clec-4(ok2050);yaEx61 0.469 n. s. 
MY1066 clec-4(ok2050);yaEx59 MY1068 clec-4(ok2050);yaEx61 0.194 n. s. 
N2 wild type MY1066 clec-4(ok2050);yaEx59 0.002 ** 
N2 wild type MY1068 clec-4(ok2050);yaEx61 0.396 n. s. 
a Comparison strain 1 against strain 2. 
b n. s., not significant. 




Figure 5. Avoidance assay of out-crossed C. elegans clec mutants on PA14. Based on the results of the clec 
mutant survival screen (Chapter II), we chose two clec genes which showed opposite survival phenotypes on 
PA14 – clec-39 was more resistant, clec-43 more susceptible – as well as C54G4.4 with a profound pathogen 
avoidance behavior on BT (Chapter II). Before conduction of assay each worm strain was back-crossed 3x with 
wild type N2. Enriched 9 cm NGM (0.35% peptone) plates were inoculated with 30 µl E. coli OP50 at OD 5 as non-
pathogenic control or PA14 mixed with E. coli OP50 in dilution 1:3. On every plate an 80 µl ring of E. coli OP50 at 
OD 5 was pipetted surrounding the spot in the middle at a 1.5 cm distance. The plates were incubated for 24 h 
at 37 °C and another 24 h at 25 °C at which the PA14 survival assay was conducted. Ten synchronized L4 larvae 
per plate were picked into the middle at 0 hpi. Worms residing on the bacterial spot were scored after several 
hours (x-axes). The avoidance index was defined as (initial total number of worms – worms on bacterial 
spot)/initial total number of worms. Means  SE of five replicates are shown. Significant differences were 
determined with a generalized linear mixed model (GLMM)8 always compared against the wild type per survival 
assay, and corrected for multiple comparisons with Bonferroni4. All P values can be found in Table 5. 
 
Table 5. GLMM8 on avoidance behavior of clec mutants per bacterial treatment; P adjustment with 
Bonferroni4. 
affected gene genotype strain treatment P value significance level 
clec-39 clec-39(ok2271) V RB1767 E. coli OP50 <0.001 *** 
clec-43 clec-43(ok3188) II RB2350 E. coli OP50 1.000 n.s.a 
C54G4.4 C54G4.4(ok2110) I RB1697 E. coli OP50 1.000 n.s. 
clec-39 clec-39(ok2271) V RB1767 PA14 1.000 n.s. 
clec-43 clec-43(ok3188) II RB2350 PA14 1.000 n.s. 
C54G4.4 C54G4.4(ok2110) I RB1697 PA14 1.000 n.s. 
a n. s., not significant. 
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 Figure 6. Systematic clec RNAi screen on BT. All RNAi 
clones used which were available from the Ahringer8 
or  Marc Vidal9 library (Table 6). L4440 vector inserts 
were sequenced (amplification with forward 
5’-GTTTTCCCAGTCACGACGTT-3’ and reverse primer 
5’-TGGATAACCGTATTACCGCC-3’9), the results are to 
be found in Table 6. Transgenic strain frIS7 was used, 
which harbors a red pcol-12::RFP construct next to 
green pnlp-29::GFP10. This particular strain was 
chosen as dead worms showed either blurry or no 
fluorescence in the epidermis while living worms 
showed distinct fluorescence. Starting from L1 larval 
stage worms were fed with the respective RNAi clone 
prior to infection according to standard protocols11. 
Obvious phenotypic knock-downs were applied to 
ensure the success of RNAi (Table 7). 30-50 L4 larvae 
were pipetted onto PFM seeded with a mixture of 
BT18247 and E. coli OP50 at OD 5 in PBS. The two 
different shades of red represent the two different 
concentrations (conc). The worms were washed off 
the plates 24 hpi with M9 buffer and scored according 
to their fluorescence in M9 droplets. Each clec gene 
was tested in three completely independent 
replicates per BT concentration. For final hit selection 
(selection of candidate genes) the z* score was 
employed12: (Yi - ỸN)/MADN with Yi = response variable 
(proportion of alive individuals), ỸN = median of 
negative reference (median of all response variables 
per week), and MAD = median of absolute deviation. 
The dashed vertical lines represent the cut-off which 
is defined as median  k*MAD (k = 3, according to 3-
sigma rule). Replicates outside the cut-off were 
considered as hits. Data of non-pathogenic control 
BT407 in dilution of 1:50 are not displayed as viability 
of worms was not impaired in any RNAi treatment 
(and the MAD would consequently be 0). (B) is a 
subset of the main data set (A) and only includes clec 
genes, for which knock-out mutants were tested 
beforehand (Chapter II).  
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Table 6. RNAi clones of Ahringer library used in RNAi screen (Figure 6). 
lab code affected gene Ahringer librarya remarks 
327 clec-1 V-4K08 confirmed by sequencing 
233 clec-2 II-2N06 confirmed by sequencing 
189 clec-3 II-2L16 confirmed by sequencing 
222 clec-8 II-8M14 confirmed by sequencing 
170 clec-9 V-11M17 confirmed by sequencing 
187 clec-10 II-1M19 confirmed by sequencing 
234 clec-11 I-6E18 confirmed by sequencing 
235 clec-12 I-6G02 confirmed by sequencing 
311 clec-15 I-6K14 confirmed by sequencing 
185 clec-17 I-6C22 confirmed by sequencing 
188 clec-19 II-2G11 confirmed by sequencing 
291 clec-21 n. a.b separately obtained; confirmed by sequencing 
238 clec-22/clec-32 V-11C10 confirmed by sequencing 
106 clec-24 V-11C12 confirmed by sequencing 
166 clec-26 V-11A20 confirmed by sequencing 
239 clec-27 V-11A24 confirmed by sequencing 
114 clec-28 V-11C14 confirmed by sequencing 
333 clec-29 V-11O13 confirmed by sequencing 
122 clec-33 V-11C18 confirmed by sequencing 
332 clec-34 V-11O11  
240 clec-35 V-11C02 confirmed by sequencing 
334 clec-38 V-11O15 confirmed by sequencing 
331 clec-39 V-11O09 confirmed by sequencing 
242 clec-41 V-8P17 confirmed by sequencing 
201 clec-42 V-11P18 confirmed by sequencing 
314 clec-43 II-1F11 confirmed by sequencing 
258 clec-44 n. a. obtained separately; confirmed by sequencing 
182 clec-47 V-9N12 confirmed by sequencing 
171 clec-48 V-11N18 confirmed by sequencing 
335 clec-49 V-12F14  
211 clec-51 IV-4K03 confirmed by sequencing 
212 clec-52 IV-4K07 confirmed by sequencing 
146 clec-53 I-1L19 confirmed by sequencing 
290 clec-55 n. a. obtained separately; confirmed by sequencing 
227 clec-56 V-9D13 confirmed by sequencing 
151 clec-58 II-7G14 confirmed by sequencing 
315 clec-60 II-7G20 confirmed by sequencing 
301 clec-61 II-10I15 confirmed by sequencing 
316 clec-63 II-8B17  
317 clec-64 II-8B19 confirmed by sequencing 
318 clec-65 II-8B21 confirmed by sequencing 
319 clec-66 II-8B23  
326 clec-69 IV-8J17 confirmed by sequencing 
118 clec-71 IV-8H19 confirmed by sequencing 
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lab code affected gene Ahringer librarya remarks 
243 clec-73 IV-8J13 confirmed by sequencing 
213 clec-74 IV-8J09 confirmed by sequencing 
113 clec-76 IV-8J05 confirmed by sequencing 
134 clec-77 IV-8J15 confirmed by sequencing 
244 clec-78 IV-2A15 confirmed by sequencing 
250 clec-79 IV-2A19 confirmed by sequencing 
125 clec-86 X-3B14 confirmed by sequencing 
253 clec-88 II-4P15 confirmed by sequencing 
183 clec-89 I-1B24  
293 clec-99 n. a. obtained separately; confirmed by sequencing 
141 clec-102 I-6I24 confirmed by sequencing 
247 clec-103 I-6M06 confirmed by sequencing 
310 clec-106 I-6F03 confirmed by sequencing 
210 clec-107 I-6J21 confirmed by sequencing 
313 clec-108 I-6L01 confirmed by sequencing 
208 clec-110 I-6N19 confirmed by sequencing 
300 clec-111 I-9F16 confirmed by sequencing 
288 clec-112c n. a. 
Marc Vidal Library ORF ID (WS9): Y71A12B.g; 
confirmed by sequencing 
245 clec-113 I-7E05 confirmed by sequencing 
209 clec-114 I-7K07 confirmed by sequencing 
248 clec-115 I-7K03 confirmed by sequencing 
254 clec-116 I-7K11 confirmed by sequencing 
186 clec-118 II-1G02 confirmed by sequencing 
246 clec-119 II-1D24 confirmed by sequencing 
137 clec-120 II-2D02 confirmed by sequencing 
136 clec-121 II-2N18 confirmed by sequencing 
190 clec-123 II-2N12  
295 clec-124 n. a. obtained separately; confirmed by sequencing 
135 clec-125 II-3E02 confirmed by sequencing 
251 clec-126 II-3C24  
191 clec-128 II-3E12 confirmed by sequencing 
148 clec-129 II-3G06 confirmed by sequencing 
147 clec-130 II-3G04 confirmed by sequencing 
192 clec-131 II-3E14 confirmed by sequencing 
255 clec-132 II-3G02 confirmed by sequencing 
256 clec-133 II-3E24 confirmed by sequencing 
257 clec-134 II-3E22 confirmed by sequencing 
216 clec-136 II-3L18 confirmed by sequencing 
259 clec-137 II-3L20  
229 clec-138 II-3L22 confirmed by sequencing 
149 clec-139 II-3L24 confirmed by sequencing 
297 clec-141 n. a. obtained separately 
150 clec-142 II-6G13 confirmed by sequencing 
262 clec-147 IV-5G06 confirmed by sequencing 
152 clec-149 III-1C18 confirmed by sequencing 
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lab code affected gene Ahringer librarya remarks 
321 clec-151 III-2G16  
221 clec-153 III-2G18 confirmed by sequencing 
299 clec-154 n. a. obtained separately; confirmed by sequencing 
154 clec-156 III-2B07 confirmed by sequencing 
155 clec-157 III-2B09  
157 clec-158 III-3J07  
156 clec-159 III-3H19 confirmed by sequencing 
219 clec-160 III-4K20 confirmed by sequencing 
158 clec-161 III-5K13 confirmed by sequencing 
117 clec-162 III-5M09 confirmed by sequencing 
264 clec-163 III-5B18  
265 clec-164 IV-1C14 confirmed by sequencing 
1 clec-165 IV-1M18 confirmed by sequencing 
266 clec-166 IV-1M08 confirmed by sequencing 
126 clec-167 IV-1M06 confirmed by sequencing 
121 clec-168 IV-1M12 confirmed by sequencing 
123 clec-170, clec-206 IV-1K24 confirmed by sequencing 
104 clec-174 IV-8H23 confirmed by sequencing 
323 clec-175 IV-2E04 confirmed by sequencing 
129 clec-176 IV-2F23 confirmed by sequencing 
130 clec-177 IV-2F21 confirmed by sequencing 
307 clec-178 IV-2N16 confirmed by sequencing 
268 clec-179 IV-3H01 confirmed by sequencing 
2 clec-180 IV-3H02 confirmed by sequencing 
231 clec-182 IV-4B01 confirmed by sequencing 
205 clec-183 IV-4F16 confirmed by sequencing 
269 clec-184 IV-6J13 confirmed by sequencing 
270 clec-185 IV-6J17  
271 clec-186 IV-6H02 confirmed by sequencing 
193 clec-187 IV-6F24 confirmed by sequencing 
160 clec-188 IV-7N21 confirmed by sequencing 
223 clec-190 IV-7N23 confirmed by sequencing 
159 clec-191 IV-7J22 confirmed by sequencing 
161 clec-193 IV-8C09 confirmed by sequencing 
162 clec-194 IV-8C19 confirmed by sequencing 
105 clec-195 IV-8G19 confirmed by sequencing 
206 clec-196 IV-8A08 confirmed by sequencing 
272 clec-197 IV-8E02 confirmed by sequencing 
165 clec-198 IV-8E04 confirmed by sequencing 
3 clec-199 IV-8E10  
273 clec-201 IV-8E14 confirmed by sequencing 
274 clec-202 IV-8E16 confirmed by sequencing 
4 clec-203 V-1H15 confirmed by sequencing 
194 clec-204 V-1L02 confirmed by sequencing 
176 clec-210 V-2F02 confirmed by sequencing 
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lab code affected gene Ahringer librarya remarks 
178 clec-211 V-5B19 confirmed by sequencing 
276 clec-212 V-5B21 confirmed by sequencing 
278 clec-213 V-5D11 obtained separately 
179 clec-214 V-5D07 confirmed by sequencing 
303 clec-215 V-14O18 confirmed by sequencing 
200 clec-216 V-5B08 confirmed by sequencing 
196 clec-217 V-5B12 confirmed by sequencing 
277 clec-221 V-7D13 confirmed by sequencing 
220 clec-222 V-7N23 confirmed by sequencing 
109 clec-226 V-9O03 confirmed by sequencing 
328 clec-227 V-9D09 confirmed by sequencing 
304 clec-228 V-16G24 confirmed by sequencing 
329 clec-230 V-10G19 confirmed by sequencing 
131 clec-231 V-10G17 confirmed by sequencing 
133 clec-232 V-10J05 confirmed by sequencing 
280 clec-234 V-11A13 confirmed by sequencing 
112 clec-238 V-11G20 confirmed by sequencing 
281 clec-239 V-11G18 confirmed by sequencing 
305 clec-241 V-16J02 confirmed by sequencing 
107 clec-242 V-11F15 confirmed by sequencing 
292 clec-245 n. a. obtained separately 
289 clec-246c n. a. 
Marc Vidal Library ORF ID (WS9): F16H6.2; 
confirmed by sequencing 
116 clec-247 V-12C13 confirmed by sequencing 
119 clec-248 V-12C23 confirmed by sequencing 
202 clec-250 V-12A14 confirmed by sequencing 
203 clec-251 V-12A10  
283 clec-254 V-12A04 confirmed by sequencing 
204 clec-255 V-12O19 confirmed by sequencing 
195 clec-259 V-12F20 confirmed by sequencing 
108 clec-261 V-12P14 confirmed by sequencing 
284 clec-262 V-12P08 confirmed by sequencing 
306 clec-263 V-14B17 confirmed by sequencing 
173 clec-264 V-13A16 confirmed by sequencing 
330 C06B8.7 V-10O19 confirmed by sequencing 
296 C43H6.6 n. a. confirmed by sequencing 
230 C49C3.11 IV-8C24 confirmed by sequencing 
9 C54G4.4 I-3P06 confirmed by sequencing 
337 cwp-5 X-6M19 confirmed by sequencing 
324 egas-4 IV-3D06  
124 F28B4.3 X-2K13 confirmed by sequencing 
111 F40F4.6 X-2M01 confirmed by sequencing 
180 F52E1.2 V-6C01  
10 F55H12.3 I-4M02 confirmed by sequencing 
139 K04H8.2 I-7K13 confirmed by sequencing 
5 lat-2 II-3F02 confirmed by sequencing 
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lab code affected gene Ahringer librarya remarks 
236 oac-17 I-6N13 confirmed by sequencing 
325 svh-1 IV-4K11  
336 T25C12.3 X-5B23 confirmed by sequencing 
294 Y17D7B.5 n. a. confirmed by sequencing 
225 Y38H6C.8 V-13E13 confirmed by sequencing 
a Well plate position of RNAi clones taken from basic Ahringer library (unless stated otherwise), clones in bold letters are part of the 
supplementary set. 
b n. a., not available. 
c Provided by the Ewbank lab (Olivier Zugasti). 
 
Table 7. RNAi clones, which cause an obvious phenotype in wild type worms and were used as positive 
controls. 
lab code affected gene Ahringer librarya phenotype remarks 
15 plc-3 II-7O15 sterile confirmed by sequencing 
16 unc-22 IV-6K06 twitching, paralyzed confirmed by sequencing 
355 bli-3 I-1A05 blistered   
a Well plate position of RNAi clones taken from basic Ahringer library. 
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Figure 7. Survival assays of clec RNAi-treated C. elegans upon exposure to BT. Prior to infection wild type N2 
worms were subjected to RNAi by feeding to knock-down specific clec genes (Table 6 and 11). For each RNAi 
treatment 30 synchronized L4 larvae per plate were exposed to pathogenic BT18247 or BT18679 mixed with 
E. coli OP50 at OD 5 in serial dilutions in PBS (x-axes). Alive and dead animals were scored 24 hpi. Worms were 
considered to be dead when they did not respond to light touch. BT407 was used as non-pathogenic control in 
the highest BT concentration applied for BT18247 per assay. For a detailed description see Chapter III, “Materials 
and Methods”. Survival was defined as proportion of alive individuals (y-axes) and is displayed as means  SE of 
five replicates. Significant differences were determined with a GLM3, always compared against the wild type per 
bacterial treatment and survival assay, and corrected for multiple comparisons with Bonferroni4. All P values can 
be found in Table 8.(A) We were interested in further analyzing clec-186 function, because its expression was 
found to be differentially expressed between the two pathogenic BT strains BT18247 and BT18679 in another 
study of our group (unpublished data). There was, however, no difference in survival between clec-186 RNAi-
treated and control worms, neither on BT18247, nor on BT18679. (B) Based on the results of the clec RNAi screen 
and additional characteristics collected from WormBase (Version WB250), five clec genes with at least one hit 
were chosen. The susceptibility phenotype of the clec RNAi screen (Figure 6) could not be confirmed in either of 
these genes, clec-116, clec-123, and clec-178 even showed the opposite with being more resistant to BT. 
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Table 8. GLM3 on survival of clec knock-down strains per bacterial treatment and survival assay; P adjustment 
with Bonferroni4. 
affected gene RNAi clone treatment Figure P value significance level 
clec-186 IV-6H02 BT18247 6A 0.105 n. s.a 
clec-186 IV-6H02 BT18679 6A 0.574 n. s. 
clec-116 I-7K11 BT18247 6B <0.001 *** 
clec-123 II-2N12 BT18247 6B <0.001 *** 
clec-178 IV-2N16 BT18247 6B <0.001 *** 
C43H6.6b  BT18247 6B 1.000 n. s. 
F40F4.6 X-2M01 BT18247 6B 0.312 n. s. 
a n. s., not significant. 




Figure 8. Expression of reporter strain pclec-41::GFP (MY1077). Exemplary pictures of transgenic worms carrying 
the reporter construct pclec-41::GFP and co-injection marker pmyo-2::RFP (expressed in pharynx). For more 
information about the generation of the transgenic strain see Table 9. Adult (upper panel) and larval stages (mid 
panel) exhibit constitutive expression of clec-41 in cells of the intestine, both in the cytosol and the nuclei. No 
change of expression in worms infected with BT18247 (lower panel). The scale bars represent 100 µm. Pictures 
were taken with Axio Observer Z.1 by Zeiss (Carl Zeiss AG, Jena, Germany). DIC, differential interference contrast; 





Figure 9. Expression of reporter strain pclec-43::GFP (MY1040). Exemplary pictures of transgenic worms carrying 
reporter construct pclec-43::GFP and co-injection marker pmyo-2::RFP (expressed in pharynx). For more 
information about the generation of the transgenic strain see Table 9. Adult (upper panel) and larval stages (mid 
panel) exhibit constitutive expression of clec-43 exclusively in the first intestinal ring of the intestine int1, both 
in the cytosol and the nuclei. No change of expression in worms infected with PA14 (lower panel). The scale bars 
represent 100 µm in the upper and 20 µm in mid and lower panels. Pictures were taken with the confocal 
microscope LSM 700 (upper panel) and Axio Observer Z.1 by Zeiss (Carl Zeiss AG, Jena, Germany). DIC, differential 
interference contrast; fluorescence, GFP filter; merged, both channels combined by using ImageJ 1.50d 




Figure 10. Expression of reporter strain pclec-186::GFP (MY1051). Exemplary pictures of transgenic worms 
carrying reporter construct pclec-186::GFP and co-injection marker pmyo-2::RFP (expressed in pharynx). For 
more information about the generation of the transgenic strain see Table 9. Adult and larval stages (not shown) 
exhibit constitutive expression of clec-186 in cells of the intestine, both in the cytosol and the nuclei. No change 
of expression in worms infected with BT18247 (mid panel) nor BT18679 (lower panel). The scale bars represent 
100 µm. Pictures were taken with Axio Observer Z.1 by Zeiss (Carl Zeiss AG, Jena, Germany). DIC, differential 
interference contrast; fluorescence, GFP filter; merged, both channels combined by using ImageJ 1.50d 
processing package Fiji (http://fiji.sc/Fiji). 
  
Table 9. Transgenic clec gene reporter strains and the primer sequencesa of the injected fusion construct13. 





























































































































































a Primers for gfp coding sequence plus 3'-UTR of unc-54 amplified from Fire vector pPD95.75: primer C, 5’-agcttgcatgcctgcaggtcgact-3’ (SHP408), primer D, 5’-aagggcccgtacggccgactagtagg-3’ (SHP409), primer D*, 
5’-ggaaacagttatgtttggtatattggg-3’ (SHP410). 
b GFP construct injected at a concentration of approx. 10 ng/µl, RFP co-injection marker at a concentration of 25 ng/µl. 
c Injected by Eike Strathmann; transgenic strain not available anymore. 
d Capital letters, overlapping sequence to gfp vector. 
 
Table 10. Transgenic strains crossed in clec-43(ok3188) mutant background. 
MY strain genotype description 
MY1049 clec-43(ok3188) II; kcIs6 [ifb-2::CFP] IV clec-43(ok3188) crossed with kcIs6 [ifb-2::CFP] (provided by Olaf Bossinger); for more details see 14 
MY1050 clec-43(ok3188) II; dkIs92[pvha-6::GFP:rab-8] clec-43(ok3188) crossed with dkIs92[pvha-6::GFP:rab-8] (provided by Miyuki Sato); for more details see 15 
  
 
Table 11. Transgenic clec gene rescue strains and the primer sequences of the injected amplicon or fusion construct13. 

























































a Approx. concentration of injected amplicon or fusion construct; RFP co-injection marker injected at a concentration of 25 ng/µl. 
b Injected by Anke Kloock. 
c Construct of clec-4 gene fused to 3'-UTR of unc-54 amplified from Fire vector pPD95.75: primer C, 5’- catctcgcgcccgtgcctctgact-3’ (SHP724), primer D, 5’-aagggcccgtacggccgactagtagg-3’ (SHP409), primer D*, 5’-
ggaaacagttatgtttggtatattggg-3’ (SHP410). 
d Capital letters, overlapping sequence to unc-54 3’-UTR.
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List of Abbreviations 
ADF amphid with dual ciliated sensory endings 
AIY amphid interneuron 
AMP antimicrobial peptide 
ASABF Ascaris suum antimicrobial factor 
ATF cAMP-dependent transcription factor 
ATFS activating transcription factor associated with stress 
AWB amphid wing "B" 
AWC amphid wing "C" 
BRE Bacillus-toxin resistant 
BT Bacillus thuringiensis 
cAMP cyclic adenosine monophosphate 
Cas CRISPR associated protein 
CBB Coomassie brilliant blue 
CCP complement control module 
Ce-ABF C. elegans antimicrobial factor 
CGC Caenorhabditis Genetics Center 
CLEC C-type lectin 
CLR C-type lectin receptor 
CNC caenacin 
collectin collagen-containing C-type lectin 
CRD carbohydrate-recognition domain 
CRISPR clustered regularly interspaced short palindromic repeats 
Cry crystal 
CTLD C-type lectin-like domain 
CUB C1r/C1s Uegf Bmp1 
CW conserved cysteine and tryptophan residues 
DAF abnormal dauer formation 
DAMP damage-associated molecular pattern  
DCAR dihydrocaffeic acid receptor 
Dectin dendritic cell-associated C-type lectin 
DIC differential interference contrast 
DL Drosophila lectin 
DNGR dendritic cell natural killer lectin group receptor 
DRH dicer related helicase 
ELT erythroid-like transcription factor family  
ERK extracellular signal-regulated kinase 
FDR false discovery rate 
FoxO Forkhead box protein class O 
FREP fibrinogen-related protein 
FSHR mammalian follicle stimulating hormone receptor 
GFP green fluorescent protein 
GlcNAc N-acetyl-glucosamine 
GLH germline RNA helicase 
GLM generalized linear model 
GLMM generalized linear mixed model 
GPCR G protein-coupled receptor 
HECT homologous to the E6-AP carboxyl terminus 
HECW HECT domain-containing E3 ubiquitin ligase 
HLH helix loop helix 
HPLA 4-hydroxyphenyllactic acid 
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Ig immunoglobulin 
ILR insulin-like receptor  
ILYS invertebrate lysozyme 
INS insulin-related protein 
IRE IRE kinase-related protein 
ITAM immunoreceptor tyrosine-based activation motif 
ITIM immunoreceptor tyrosine-based inhibitory motif 
JNK c-Jun N-terminal kinase  
KGB GLH binding kinase 
LB lysogeny broth 
LPS lipopolysaccharide 
LYS lysozyme 
MAD median of absolute deviation 
MAMP microbe-associated molecular pattern  
MAPK p38 mitogen-activated protein kinase  
MASP MBL-associated serine protease 
MBL mannose -binding lectin 
MDL myeloid DAP12-associated lectin 
MEK-1 dual specificity MAPK kinase 
MICL myeloid inhibitory C-type lectin-like receptor 
Mincle macrophage-inducible C-type lectin 
MR mannose receptor 
MyD88 myeloid differentiation primary response gene 88 
NBRP National BioResource Project 
NF-κB nuclear factor κ-light-chain-enhancer of activated B cells 
NGM nematode growth medium 
NLP neuropeptide-like peptide 
NLR NOD-like receptor 
NOD nucleotide-binding oligomerization domain 
NPR neuropeptide receptor 
NSY neuronal symmetry 
OCTR octopamine receptor 
OD optical density 
OLL outer labial lateral sensilla 
PA Pseudomonas aeruginosa 
PBS phosphate-buffered saline 
PCR polymerase chain reaction 
PFM peptone-free medium 
PFT pore-forming toxin 
PMK p38 MAPK 
PRR pattern recognition receptor 
qRT-PCR quantitative real-time PCR 
Reg regenerating gene family protein 
RFP red fluorescent protein 
RIG retinoic acid-inducible protein 
RLR retinoic acid-inducible gene-I-like receptor 
RNA ribonucleic acid 
ROS reactive oxygen species 
SAPK stress-activated protein kinase 
SD standard deviation 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SE standard error 
SEK SAPK/ERK kinase 
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SPP saposin-like protein 
Syk spleen tyrosine kinase 
TIR Toll-interleukin receptor  
TLR Toll-like receptor  
TOL TOLI (Drosophila) family 
TPH tryptophan hydroxylase 
UPR unfolded protein response 
UPRmt mitochondrial UPR 
UTR untranslated region 
VCBP variable region-containing chitin-binding protein 
VHP VH1 dual specificity phosphatase family protein 
VWA von Willebrand factor A 
XBP x-box binding protein 
YPD yeast extract peptone dextrose 
ZIP bZIP transcription factor family 
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